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ABSTRACT 
CHRISTOPHER D. SPROUL: Biological Responses to Ultraviolet Radiation and the Effect 
of Intra-S Checkpoint Inhibition on Ultraviolet Radiation-Induced Mutagenesis 
(Under Direction of Marila Cordeiro-Stone, PhD) 
 
 
Sunlight emits a spectrum of electromagnetic radiation that includes ultraviolet, 
visible, and infrared wavelengths. It is widely accepted that the ultraviolet radiation (UVR) 
component is responsible for the mutagenic and carcinogenic effects of sunlight. UVR is 
further sub-divided into three wavelength ranges: UVC (100-280 nm), UVB (280-315 nm) 
and UVA (315-400 nm) and each of these induce differing types and proportions of DNA 
damage. Despite much research, there is debate about the relative contributions from 
different wavelengths in initiating and promoting mutagenesis and carcinogenesis. DNA 
damage responses have been widely characterized using UVC, which is effectively filtered 
out by the Earth’s atmosphere, while comparatively fewer studies have been conducted 
utilizing UVA and UVB. The research reported here assessed the biological outcomes of 
irradiating human dermal fibroblasts with UVR of different wavelengths, using DNA damage 
dosimetry to allow comparison between different irradiation sources. Cylobutane pyrimidine 
dimer (CPD) and 6-4 pyrimidine-pyrimidone photoproduct (6-4PP) densities were quantified 
and used as biomarkers following irradiation with lamps emitting UVA, UVB, or UVC. 
Comparing fluences that produced equal CPD densities, cytotoxicity, intra-S phase 
checkpoint response, and mutagenesis were assessed. Regardless of the source of UVR, 
results showed a striking similarity in the biological outcomes measured when exposures 
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were compared on the basis of CPD dosimetry, suggesting that this UV-induced photolesion 
significantly contributed to the measured effect. 
The S-phase checkpoint response to UVR is a signaling cascade that recognizes 
damaged DNA or abnormal DNA structures and halts or slows new/ongoing DNA 
replication, potentially reducing the chance that damaged DNA will be replicated prior to its 
repair. Experiments reported here tested the hypothesis that this checkpoint is a protective 
system that reduces UVR-induced mutagenesis. Essential S-phase checkpoint components 
ATR or CHK1 were depleted using siRNA, or the CHK1 kinase pharmacologically inhibited 
using TCS2312, thereby inhibiting the S-phase checkpoint response to UVR. Subsequently, 
the UVR-induced mutation frequency at the HPRT locus was measured. Results showed 
that despite reversing the S-phase checkpoint response to UVR, the mutation frequency in 
the irradiated population was not increased, challenging the broadly accepted role of this 
signaling cascade in minimizing mutation burden.
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PREFACE 
Research presented in Chapter 2 compared biological responses of normal human 
fibroblasts (NHF1) to three sources of ultraviolet radiation (UVR), each emitting primarily 
UVA, UVB, or UVC wavelengths. The endpoints measured were cytotoxicity, intra-S 
checkpoint activation, inhibition of DNA replication, and mutagenicity. The overall goals of 
this project were to examine mechanisms of UV-induced intra-S checkpoint activation and 
the influence of the intra-S checkpoint on mutagenesis. Little is known about how different 
wavelengths of UVR contribute to intra-S checkpoint activation or how different wavelengths 
of UVR contribute to UV-induced mutagenesis. These studies used DNA damage dosimetry 
to allow comparisons between three different wavelength ranges of UVR and to characterize 
activation of the intra-S checkpoint by different wavelengths. In addition, mutagenesis 
induced by different wavelengths was assessed on the basis of DNA damage dosimetry. 
DNA damage dosimetry was performed to quantify levels of CPD (both by 
immunoblot and RIA), 6-4PP, and 8-oxo-dG. Assay of CPD and 6-4PP by RIA were 
performed in the laboratory of Dr. David Mitchell using DNA purified from irradiated cells by 
Chris Sproul. The purification of DNA for the assay of 8-oxo-dG and the assay itself were 
performed by the UNC-CEHS using irradiated cells provided by Chris Sproul. The 
immunoblot showing DNA damage responses in NHM (see Figure S2.1) was provided by 
Dr. William Kaufmann and Dr. Dennis Simpson. The CPD and 6-4PP repair kinetic curves in 
NHM and NHF (see Figure S2.2) were also provided by Dr. William Kaufmann, with the 
experiment being performed in his laboratory and the dosimetry performed in the laboratory 
of Dr. David Mitchell. Statistical analysis was performed by Shangbang Rao and Dr. Joseph 
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Ibrahim. All other work presented in this chapter, including CPD dosimetry, cytotoxicity 
experiments, intra-S checkpoint experiments, and mutagenesis experiments were performed 
by Chris Sproul. The contents of this chapter are being prepared as a manuscript to be 
submitted to Photochemistry and Photobiology. 
The research presented in Chapter 3 examines the effect of intra-S checkpoint 
inhibition on UV-induced mutation frequency. The overall goals of this project were to 
examine mechanisms of UV-induced intra-S checkpoint activation and the influence of the 
intra-S checkpoint on mutagenesis. These experiments tested the hypothesis that intra-S 
checkpoint inhibition would increase UV-induced mutagenesis. The hypothesis was tested 
by depleting or inhibiting key components of the intra-S checkpoint signaling pathway and 
examining UV-induced mutation frequencies at the HPRT locus. 
All experiments presented in this chapter were performed by Chris Sproul, including 
all siRNA depletions, velocity sedimentation experiments, immunoblots, CHK1 inhibitor 
characterization experiments, and mutagenesis experiments. Dr. William Kaufmann 
provided valuable suggestions and regular input throughout the development of this study. 
Statistical analysis was performed by Shangbang Rao and Dr. Joseph Ibrahim. The 
contents of this chapter are being prepared as a manuscript to be submitted to 
Carcinogenesis. 
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 CHAPTER 1 
INTRODUCTION 
Cancer 
Cancer is often thought of as a disease of mis-regulated cellular proliferation and 
differentiation. Damage to the cellular genetic material, DNA, by endogenous or exogenous 
sources is widely accepted to result in permanent mutations that alter the abundance or 
function of protein-coding genes. Cancers acquire mutations in genes that regulate growth 
signaling and growth potential, control programmed cell death, and regulate differentiation, 
allowing cancer cells to grow unrestrained and to invade neighboring tissue or metastasize 
(Hanahan and Weinberg, 2000; Hanahan and Weinberg, 2011). Mutations in cancer cells 
also allow tumors to facilitate the growth of their own blood supply (angiogenesis), and to 
evade host immune responses. Cancers were originally thought to result from the mutation 
of one or only a few genes. It is now widely accepted that cells acquire mutations to perhaps 
a dozen or more genes in progressive steps toward malignancy. Furthermore, cancer cells 
appear to acquire mutations at abnormally high rates, further selecting for cells with 
mutations in each of these key hallmark pathways (Beckman and Loeb, 2005; Loeb, 1991). 
This mutator phenotype can occur when primary mutations disrupt the cell’s genome 
surveillance and maintenance systems that would normally detect and resolve aberrant 
genomic material. These DNA-maintenance pathways usually ensure that spontaneous 
mutation rates remain low, and disruptions to these protective pathways can promote the 
genomic instability that results in the mutator phenotype.  
Genome maintaining pathways detect damaged DNA or aberrant DNA structures 
and activate subsequent systems designed to repair or tolerate the damage and/or prevent 
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the damaged DNA from being replicated. Cells have evolved multiple pathways to repair 
specific forms of damaged DNA. Homologous recombination, mismatch repair, non-
homologous end joining, base excision repair (BER), and nucleotide excision repair (NER) 
are among the pathways that cells use to repair damaged DNA (Sancar et al., 2004). Germ-
line mutations have fostered much of our understanding of how disruptions to these repair 
pathway genes promote enhanced mutagenesis. For example, individuals with the genetic 
disorder xeroderma pigmentosum most often harbor an inherited mutation in genes 
regulating NER, diminishing their capacity to repair NER substrates, such as those induced 
by ultraviolet radiation (UVR). These individuals exhibit extreme sensitivity to UVR and 
acquire UVR-induced skin cancers at rates 2000-10000 higher than normal (Lehmann et al., 
2011). Similarly, individuals with Bloom’s syndrome present with elevated cancer incidence 
and have been shown to have defects in homologous recombination.  
Tightly linked with repair pathways, cell cycle checkpoints monitor the transition 
between the phases of the cell cycle and inhibit cell cycle progression when damaged DNA 
or aberrant genomic structures are detected. The somatic cell cycle ensures that the 
genome is completely and accurately replicated once and only once during S-phase, and 
that the duplicated genome is segregated to identical daughter cells during mitosis. 
Progression through the cell cycle with damaged DNA, abnormal DNA structures, or 
insufficient resources to carry out cellular duplication faithfully can lead to genetic instability. 
Cell cycle checkpoints survey cell cycle phases and their transitions to inhibit progression in 
the presence of such damage, and are thought to allow cells time to repair genomic damage 
before it is replicated (Kastan and Bartek, 2004; Kaufmann and Paules, 1996; Shackelford 
et al., 1999). Inherited or somatic mutations to checkpoint genes are also thought to 
potentially contribute to the mutator phenotype. For example, individuals with the genetic 
instability syndrome ataxia telangiectasia inherit mutations to the ATM (ataxia telangiectasia 
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mutated) gene and display a predisposition to cancer. ATM is a protein kinase involved in 
sensing chromatin structures associated with DNA double strand breaks and facilitates the 
activation of multiple cell cycle checkpoints and DNA repair pathways. Because such 
genetic disorders have provided some mechanistic insight into cancer initiation and 
progression, researchers continue to examine these and other pathways that contribute to 
DNA damage repair and tolerance in hopes of elucidating molecular mechanisms of 
carcinogenesis and perhaps improving cancer prevention or therapeutics. 
Skin cancers and UVR 
Skin cancers are the most common form of human malignancy, with more than three 
million new cases of non-melanoma skin cancer (NMSC) and more than 70,000 new cases 
of malignant melanoma projected for the USA in 2012 (www.cancer.org; ACS cancer facts 
and figures 2012). Skin cancers predominantly occur as melanoma or NMSC, which is 
largely divided into basal and squamous cell carcinomas (BCC and SCC, respectively).  
While BCC is the most common malignancy in Caucasians and the most common NMSC, 
accounting for ~80% of all NMSC, it rarely metastasizes and thus displays relatively low 
mortality rates. SCC accounts for ~20% of all NMSC, but is more likely than BCC to invade 
and metastasize and thus results in higher mortality than does BCC. Although melanoma is 
much less common than NMSC, accounting for ~3% of all skin cancers in the USA, it 
accounts for more than 75% of all skin cancer deaths.  Exposure to solar ultraviolet radiation 
(UVR) is the primary environmental risk factor for all forms of skin cancer. 
Cellular DNA is damaged through direct absorption of UVR wavelengths and also 
potentially through indirect energy transfer via endogenous photosensitizers. In addition to 
direct genotoxic effects, acute dermal exposure to UVR can cause inflammatory erythema 
(i.e. sunburn), tanning (increased melanogenesis), epidermal hyperplasia (skin thickening), 
and local immune suppression. Increased skin cancer rates in immunosuppressed 
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individuals suggests immune involvement in skin cancer protection (Hill, 1976; Hoxtell et al., 
1977), and also provides a plausible reason to suspect local UVR-induced 
immunosuppresion as a risk factor for disease progression. In addition to photoaging, 
chronic dermal exposure to UVR causes accumulation of DNA damage that can lead to 
mutations, which combined with further immune suppression are thought to lead to skin 
carcinogenesis (Ichihashi et al., 2003; Matsumura and Ananthaswamy, 2004).   
Because UVR is a direct mutagen and also causes cellular proliferation and immune 
suppression, it is considered a prototypical complete carcinogen that contributes to each 
stage of the initiation, promotion, and progression model. As with other carcinogens, UVR 
can cause mutations that lead to the activation of oncogenes and the inactivation of tumor 
suppressor genes. Common UVR mutations in NMSC are found in the tumor suppressor 
genes p53 and PATCHED (PTC), the CDKN2A locus encoding both p16INK4a and p19ARF, 
and members of the RAS family of oncogenes (Matsumura and Ananthaswamy, 2004). 
Common mutations identified in melanomas include activation of the oncogenes BRAF or 
NRAS, loss of PTEN, or other mutations that activate the PI3K pathway, and TGF-β 
(Matsumura and Ananthaswamy, 2004).  
Sunlight is a continuous spectrum of electromagnetic radiation that includes 
ultraviolet, visible, and infrared wavelengths (Figure 1.1).  The UVR spectrum can be further 
sub-divided into three wavelength ranges: UVC (100-280 nm), UVB (280-315 nm) and UVA 
(315-400 nm). In contrast to UVA and UVB, the wavelengths in the UVC range are absorbed 
by the Earth’s stratospheric ozone layer and do not reach the surface of the planet.  UVR 
that does reach the surface of the planet consists of approximately 5-10% UVB and 90-95% 
UVA. Much research has been devoted to deciphering the biological effects elicited by 
different wavelengths of UVR and to determine how different wavelengths contribute to 
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Figure 1.1 The solar spectrum of electromagnetic radiation. Sunlight is a continuous 
spectrum of electromagnetic radiation that includes ultraviolet, visible, and infrared 
wavelengths.The UVR spectrum is further sub-divided into three wavelength ranges: UVC 
(100-280 nm), UVB (280-315 nm) and UVA (315-400 nm). UVC is absorbed in the 
stratospheric ozone layer, while UVB and UVA reach the Earth’s surface. [Adapted from 
Matsumura and Ananthaswamy, Appl Parmacol 2004 Mar 15;195(3):298-308]  
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mutagenesis and carcinogenesis. Despite the volume of research devoted to this topic, 
there is still much controversy surrounding the significance of the various UVR wavelengths. 
UVR-induced DNA damage and mutations 
Direct absorption of UVR by DNA 
The absorption spectrum for DNA ranges from approximately 200 nm to 310 nm, 
with the lowest absorption at 232 nm, and the maximum absorption at 260 nm. The direct 
absorption of UVR energy by DNA bases is known to cause photochemical reactions 
resulting in alterations to native DNA structure (reviewed in (Cadet et al., 2005; Ichihashi et 
al., 2003). These photochemical reactions induce multiple forms of base alterations, most 
commonly the formation of photodimers or photoadducts between adjacent pyrimidines. The 
most common form of UVR-induced DNA damage is the cyclobutane pyrimidine dimer 
(CPD, Figure 1.2), which is the formation of a cyclobutane ring between the C4 and C5 
carbon atoms of adjacent cytosine (C) or thymidine (T) residues. The 6-4 pyrimidine-
pyrimidone photoproduct (6-4PP, Figure 1.3) is also formed by direct absorption of UVR, 
causing a cross-link between the C6 carbon of the 5’ base with the C4 carbon of the 3’ base. 
The formation of a secondary photoproduct, the Dewer isomer, can also result from the 
photoisomerization of the 6-4PP after subsequent exposure to UVA wavelengths (Cadet et 
al., 2005; Matsunaga et al., 1991). The wavelength action spectrum for the formation of the 
CPD and 6-4PP strongly overlaps with the UV-absorption spectrum of DNA, with efficient 
formation occurring between 220 nm and 300 nm (Matsunaga et al., 1991; Mitchell et al., 
1991), although the formation of CPD has been reported at longer wavelengths 
(Courdavault et al., 2004; Mouret et al., 2006). The CPD to 6-4PP density ratio is generally 
reported as anywhere from 3 to 10 for UVR wavelengths that correspond to the DNA UV-
absorption spectrum, and even higher when examining UVR that mimics the solar spectrum 
(Besaratinia et al., 2011; Cadet et al., 2005; Mitchell et al., 1991). 
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Figure 1.2 Cyclobutane pyrimidine dimer (CPD). The most abundant UV-induced DNA 
photolesion forms between the C4 and C5 carbon atoms of adjacent pyrimidines. The CPD 
forms after direct absorption of UVR or via indirect photosensitization reactions. 
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Figure 1.3 The 6-4 pyrimidine-pyrimidone photoproduct (6-4PP). The 6-4PP is formed 
by direct absorption of UVR, causing a cross-link between the C6 carbon of the 5’ base with 
the C4 carbon of the 3’ base. 
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The UV signature mutation 
The C→T transition at dipyrimidine sites and the CC→TT tandem base substitutions 
have been termed UV-signature mutations, and have been observed in high frequencies in 
NMSC (Brash et al., 1991; Brash et al., 1996; Gailani et al., 1996; Ziegler et al., 1993). This 
signature mutation is thought to be primarily the result of accurate bypass of a CPD 
containing a deaminated cytosine (Figure 1.4) (reviewed in (Ikehata and Ono, 2011).  
Compared to an unaltered cytosine, the cytosine in a CPD is much more prone to 
deamination, resulting in the formation of uracil (U) at C-containing CPD. Upon encountering 
a CPD or 6-4PP on the template strand, the replicative polymerase is unable to replicate 
through this lesion. Specialized bypass polymerases are required to effectively replicate 
damaged DNA when the replicative polymerases are unable to do so. This trans-lesion 
synthesis (TLS) is performed by various Y-family polymerases; in the case of the CPD, TLS 
is carried out by DNA polymerase eta (pol η). Although more error prone than the replicative 
polymerases on undamaged DNA (Matsuda et al., 2000), pol η is able to accommodate the 
CPD in its active site (Yoon et al., 2009) and replicate past the lesion, thus preventing a 
prolonged arrest and potential collapse of the replication fork at the damage site, which 
would lead to the formation of a double stranded break. Accurate bypass of deaminated 
cytosines in CPD by pol η would therefore introduce an adenine opposite the uracil. 
Subsequent removal of the CPD or further replication of the A-containing strand would result 
in permanently altering the original G:C base pair to an A:T base pair (i.e., a C →T transition 
mutation).  UV-signature mutations are still the most common UV-induced mutation in cells 
derived from individuals with xeroderma pigmentosum variant (XPV), which lack functional 
pol η (Choi and Pfeifer, 2005a; Stary et al., 2003). Thus it has been argued that accurate 
bypass of deaminated cytosines by pol η cannot account for all UV-signature mutations. An 
argument has also been made for an error prone TLS-dependent model (Gueranger et al., 
2008) relying upon TLS polymerases that preferentially insert an adenine opposite damaged 
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Figure 1.4 The UVR signature mutation. This signature mutation is thought to be primarily 
the result of accurate TLS bypass of a CPD containing deaminated cytosine(s). This 
mechanism leads to C→T or CC→TT transitions at dipyrimine sites.  
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template DNA and further rely upon polymerases that can extend past such mismatches.  It 
should also be noted that UV-signature mutations following UVB or solar exposure (but not 
UVC) have been observed at higher frequencies in CPD containing 5-methyl-cytosine 
(Drouin and Therrien, 1997; Tommasi et al., 1997), which are common in mammalian CpG 
sequences. Furthermore, the presence of 5-methyl cytosine increased the CPD yield in UVB 
irradiated DNA, but not in DNA irradiated with UVC (Rochette et al., 2009). It has also been 
proposed that the 3’ methyl-cytosine in a CPD deaminates even more rapidly than an 
unmethylated cytosine in the same sequence, enriching UV signature mutations at methyl-
CpG sites (Lee and Pfeifer, 2003).  
UVA-induced DNA damage 
UVA is the most abundant and lowest energy component of solar UVR. Once 
thought relatively harmless, the UVA wavelengths have been the focus of intense research 
following evidence that exposure to sunbeds, primarily emitting UVA, increases the risk of 
NMSC and melanoma (reviewed in (Dore and Chignol, 2012). Despite the fact that energy 
from UVA is poorly absorbed by DNA, UVA has been shown to induce multiple forms of 
DNA damage. Following UVA exposure, CPD are detected in mammalian cells (Courdavault 
et al., 2004; Douki et al., 1999) and in human skin (Mouret et al., 2006; Tewari et al., 2012), 
while 6-4PP are generally not reported to be found (Besaratinia et al., 2011; Perdiz et al., 
2000). Interestingly, the distribution of CPD in UVA irradiated cells is different than those 
observed following treatment with UVB, suggesting that they are formed by different 
mechanisms. While both UVA and UVB-induced CPD occur most frequently at TT sites, 
UVB exposure produces a higher proportion of C-containing CPD than does UVA, and UVA-
induced CC-CPD are not observed (Douki et al., 2003; Mouret et al., 2006). Because DNA 
does not readily absorb UVA wavelengths, the predominant view is that the formation of 
UVA-induced CPD occurs via an indirect mechanism, relying on endogenous 
12 
photosensitizers that absorb UVA wavelengths and then deposit that energy on DNA (Cadet 
et al., 2005). Despite the weak absorption of longer wavelengths by DNA, other researchers 
have proposed that UVA is still capable of directly damaging DNA without photosensitization 
reactions. CPD were reported following irradiation of purified plasmid DNA with filtered UVA 
that was thought to be absent of any photosensitizer (Kuluncsics et al., 1999). Similarly, 
Jiang et al reported the production of CPD in purified plasmids following irradiation with 
narrow band UVA (Jiang et al., 2009). 
UVA-induced cytotoxicity and mutagenicity was shown to be at least partially oxygen 
dependent in bacteria and mammalian cells, providing evidence that molecular oxygen was 
involved in a UVA-photosensitization reaction (Danpure and Tyrrell, 1976; Webb and 
Malina, 1970). It was hypothesized that photosensitizers could undergo a direct one-electron 
reduction (type I photosensitization) and subsequent oxidation of DNA, or a transfer of 
energy to molecular oxygen (type II photosensitization) and the formation of highly reactive 
singlet oxygen (1O2) and that the formation of 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-oxo-
dG) would be the most likely form of oxidative DNA damage from either reaction. Although 
the mechanism is still in question, UVA-induced 8-oxo-dG has been reported in mammalian 
cells (Courdavault et al., 2004; Douki et al., 1999), in mouse skin (Ikehata et al., 2008), and 
in human skin (Mouret et al., 2006). It is still unclear, however, what contribution UVA-
induced oxidative damage to DNA has on UV-induced carcinogenesis. 
UVA-induced mutation spectrum 
The mutation spectrum induced by UVA in mammalian cells has been examined in 
several studies. A UVA-fingerprint mutation was proposed when Drobetsky et al observed a 
high frequency of T→G transversions in the APRT gene of UVA-irradiated Chinese Hamster 
Ovary cells (Drobetsky et al., 1995), and it was proposed that this mutation was the result of 
incorporation of 8-OH-dGTP opposite a template adenine (Figure 1.5). A similar result was 
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Figure 1.5 The mispairing of 8-oxo-dG with adenine. The most abundant damage to DNA 
induced by reactive oxygen species (ROS) is 8-oxo-dG, and long wavelength UVR has been 
reported to induce ROS-mediated 8-oxo-dG formation. Incorporation of 8-OH-dGTP 
opposite a template adenine results in T→G transversions, while mispairing of template 8-
oxo-dG with dATP is reported to induce G→T transversions. 
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reported in the p53 sequence of human squamous carcinoma (Agar et al., 2004). The 
mispairing of template 8-oxo-dG with dATP (Figure 1.5) has also been proposed as a UVA 
signature mutation and the resultant G→T transversions were observed in the CII or lacI 
transgenes following UVA irradiation of Big Blue mouse embryonic fibroblasts (Besaratinia 
et al., 2004; Besaratinia et al., 2011; Kim et al., 2007). (Besaratinia et al., 2011) 
The contribution of UV-induced oxidative damage to mutagenesis is not without 
controversy. Base excision repair deficient ogg1-/- mouse embryonic fibroblasts that are 
unable to repair 8-oxo-dG did not display enhanced UVA-induced mutagenesis (Kappes and 
Runger, 2005). Conversely, overexpression of human OGG1 decreased the UVA-induced 
mutation frequency in the hprt (hypoxanthine phosphoribosyltransferase) gene of Chinese 
Hamster Ovary cells (referred to as gprt in (Dahle et al., 2008). Furthermore, several other 
mutagenesis studies failed to find a significant contribution from UVA-induced signature 
mutations, and instead predominantly recovered C→T transitions at dipyrimidine sites in 
UVA-irradiated fibroblasts (Kappes and Runger, 2005; Kappes et al., 2006), human 
embryonic kidney cells (Robert et al., 1996a), or mouse skin (Ikehata et al., 2003; Ikehata et 
al., 2008). 
UVA and melanoma 
The role of UVA in initiating and promoting melanoma remains a controversial 
subject. Until recently, sunscreens have predominantly blocked UVB wavelengths to prevent 
erythema, allowing prolonged exposure to UVA without sunburn. It has been hypothesized 
that this increased exposure to UVA has led to increased melanoma incidence (Garland et 
al., 1993). As previously mentioned, there is evidence that exposure to tanning sunbeds, 
primarily emitting UVA, increases the risk of melanoma (reviewed in (Dore and Chignol, 
2012). Clinical/epidemiological data and animal models of UVA-induced melanoma have 
produced heterogeneous results. While early studies in the Xiphophorus fish model 
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suggested that UVA could induce melanoma (Setlow et al., 1993), these data were later 
challenged (Mitchell et al., 2010). Following 81 weeks of exposure, three times a week, 
UVA-induced melanocytic hyperplasias were reported in 22% of exposed opossum 
(Monodelphis domestica) (Ley, 1997). Mouse models of UV-induced carcinogenesis have 
largely found UVA capable of inducing NMSC, but have failed to produce melanomas (De 
Fabo et al., 2004). Clinically, UVA (mostly combined with the photosensitizer psoralen, 
termed PUVA) is used to treat cutaneous diseases such as psoriasis, scleroderma, and 
dermatitis. Patients undergoing PUVA (psoralen + UVA) are prone to develop lentigines that 
are characterized by atypical, bi-nucleate, proliferating melanocytes, and may also be more 
prone to developing melanoma (Stern et al., 1997). This result has also been challenged by 
other research (Hannuksela-Svahn et al., 1999), and because psoralen itself may initiate 
carcinogenesis, the results are difficult to interpret. 
The mutations found in melanomas themselves further confuse the contribution of 
UVA toward melanomagenesis. While melanomas frequently harbor UV signature C →T 
transitions in genes such as TP53, PTEN, and CDKN2A, mutations in NRAS and BRAF are 
commonly not UV signature mutations (Hocker and Tsao, 2007). The serine/threonine 
protein kinase BRAF is commonly mutated in cutaneous melanomas, and the majority of 
these mutations occur at or near codon 600 of exon 15, changing a valine to a glutamic acid 
(V600E). Melanoma mutations at V600 are not UV signature mutations, and cannot be 
attributed to a C→T transition at a dipyrimidine site, suggesting that these mutations may be 
the result of some other form of DNA damage, such as oxidative damage (Besaratinia and 
Pfeifer, 2008). Alternatively, it has been suggested that error-prone bypass of nearby UV-
induced photoproducts by TLS polymerases could give rise to mutations at the BRAF V600 
codon (Thomas et al., 2006). It has even been suggested that the pigment melanin itself 
may contribute to UVA-induced carcinogenesis. It is well accepted that melanin absorbs UV 
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photons that can damage DNA, but it has also been proposed that melanin can act as a 
photosensitizer for UVA wavelengths, and that the production of reactive melanin radicals 
could contribute to oxidative damage to DNA (Mitchell and Fernandez, 2012; Runger, 2011). 
Cell cycle checkpoints 
As previously mentioned, cell cycle checkpoints monitor the phases of the cell cycle 
and their transitions and inhibit cell cycle progression when damaged DNA or aberrant 
genomic structures are detected. The prevailing dogma is that cell cycle checkpoints provide 
time for repair of damaged DNA, reducing the probability that damaged DNA will be 
replicated and segregated, thus reducing mutation frequencies and chromosomal 
aberrations. Indeed, checkpoint failures have been shown to result in chromosomal 
abnormalities, developmental defects, and predisposition to cancers (Kastan and Bartek, 
2004; Kerzendorfer and O'Driscoll, 2009). Upon sensing damaged DNA, cell cycle 
checkpoints inhibit progression out of the G1 and G2 phases of the cell cycle, while the intra-
S checkpoint slows progression through S-phase (Kastan and Bartek, 2004).  
Overview: The intra-S phase checkpoint 
The intra-S phase checkpoint can be divided into two main signaling cascades that 
respond to different forms of damaged DNA (Figure 1.6). The first recognizes chromatin 
structures associated with double strand breaks (dsb) in DNA, such as those induced by 
ionizing radiation (IR). The intra-S checkpoint response to IR requires the proteins ATM, 
MRE-11, RAD50 and NBS1 and involves activation of the checkpoint kinases CHK1 and 
CHK2, promoting proteolytic degradation of CDC25A. Loss of the CDC25A phosphatase 
prevents removal of the inhibiting phosphorylation at tyr15 of CDK2, thus maintaining CDK2 
in its  
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Figure 1.6 The intra-S checkpoint. Two pathways that activate the intra-S checkpoint. The 
first, employing the sensor protein ATM, responds to double stranded breaks in DNA, such 
as those caused by ionizing radiation. This pathway relies on the ubiquitin-mediated 
proteolysis of the CDC25A phosphatase to maintain CDK2 in its inhibited state, thereby 
preventing CDC45-dependent initiation at new replication origins. The second employs the 
sensor ATR and transducer kinase CHK1, and is thought to involve inhibition of DDK (CDC7 
& DBF4) complex-dependent initiation at new replication origins. This diagram is a 
simplification as there is thought to be crosstalk between these two and other pathways, and 
many co-factors and accessory proteins have been omitted.   
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inhibited state, preventing CDC45-dependent initiation at new replication origins. ATM also 
maintains the intra-S checkpoint response by activation of p53 and subsequent induction of 
the CDK2 inhibitor p21Waf1, and also by signaling through the cohesion subunits Smc1 and 
Smc3 (Kastan and Bartek, 2004).  
The second main signaling cascade recognizes aberrant DNA structures produced 
during replication of bulky DNA adducts, such as those induced by UVR or benzo[a]pyrene 
diolepoxide (BPDE). This checkpoint response to UVR was found to require the activity of 
checkpoint proteins ataxia telangiectasia and Rad3-related (ATR) kinase, and its target 
CHK1, to act on downstream substrate(s) to inhibit the firing of new origins of replication 
(Chastain et al., 2006; Heffernan et al., 2002; Miao et al., 2003) and to slow down rates of 
DNA chain elongation (Petermann et al., 2006; Seiler et al., 2007; Unsal-Kacmaz et al., 
2007). A 15 J/m2 fluence of UVC resulted in the proteolysis of CDC25A, indicating that such 
a lethal dose activates a response that overlaps with the IR-induced activation of ATM 
(Mailand et al., 2000). At sub-lethal fluences of UVR, however, the ATR/CHK1 pathway has 
been shown not to depend on degradation of CDC25A, but rather it has been proposed to 
act on the DBF4-dependent kinase (DDK) to prevent CDC45-dependent activation of the 
MCM helicase, thus inhibiting new replicon initiation (Heffernan et al., 2007; Lee et al., 
2012).  
The ATR/CHK1 dependent intra-S phase checkpoint response to UVR 
Using velocity sedimentation in an alkaline sucrose gradient to analyze the 
abundance of different sizes of newly replicated DNA in HeLa and normal human dermal 
fibroblasts, it was observed that exposure to a sub-lethal fluence of UVR selectively inhibited 
the production of low molecular weight DNA intermediates that had initiated synthesis after 
irradiation (Kaufmann et al., 1980b). This selective inhibition occurred for DNA intermediates 
that were roughly half the size of an average replicon leading to the interpretation that low 
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fluence UVR was inhibiting the firing of new origins of replication. It is now understood that 
when the replication fork encounters a template strand photoproduct, the replicative 
polymerase is stalled and uncoupled from the helicase, generating regions of single 
stranded DNA that initiate the intra-S checkpoint signaling (reviewed in (Kaufmann, 2009).  
A similar phenomenon had also been observed in IR-exposed cells and it was 
determined that cells derived from patients with ataxia telangiectasia were resistant to IR-
induced inhibition of DNA synthesis (Painter and Young, 1980). It has since been 
discovered that individuals afflicted with ataxia telangiectasia harbor inactivating mutations 
in ATM, which produces a protein product sharing homology with yeast and mammalian 
phosphatidylinositol-3' kinases (PI3K)  (Savitsky et al., 1995). ATM has since been shown to 
act as a serine/threonine kinase that responds to double stranded breaks in DNA and 
phosphorylates many targets to inhibit cell cycle progression. Because UVR and IR-
irradiated cells shared a similar inhibition of DNA synthesis, and because cells lacking 
functional ATM displayed a radioresistant phenotype, it was initially hypothesized that ATM 
might also be involved in the UVR-induced inhibition of DNA synthesis (Painter, 1985). It 
was, however, eventually determined that ATM-/- cells retained an effective intra-S 
checkpoint response following treatment with UVC (Heffernan et al., 2002), indicating that 
ATM was not required for UV-induced inhibition of replicon initiation. 
ATR was identified as a human gene closely related to the yeast genes Rad3 (S. 
pombe) and Mec1 (S. cerevisiae), and the Drosophila gene mei-41, all of which were 
reported to produce PI3K proteins involved in DNA damage checkpoints. Furthermore, 
expression of the human ATR gene product in S. cerevisiae also complemented the IR-
induced sensitivity in esr1-1 mutant yeast (inactivating mutation of Mec1) (Bentley et al., 
1996). Unlike ATM, ATR was found to be an essential gene whose deletion caused 
embryonic lethality in mice (Brown and Baltimore, 2000; de Klein et al., 2000). The genetic 
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disorder Seckel syndrome is a consequence of an ATR hypomorphic splice mutant, and 
manifests as a developmental disease, with patients exhibiting dwarfism, microcephaly, and 
mental retardation. Cancer, however, is not typically associated with the disorder 
(Kerzendorfer and O'Driscoll, 2009). In addition to binding UV-damaged DNA (Unsal-
Kacmaz et al., 2002), ATR distributes into nuclear foci following treatment with aphidicolin 
(Tibbetts et al., 2000). Further studies identified ATRIP (ATR interacting protein) co-
localizing with ATR after treatment with UVR (Cortez et al., 2001), and that this nuclear 
localization was inhibited following siRNA depletion of the single stranded DNA binding 
protein RPA (Zou and Elledge, 2003). Expression of kinase dead ATR was shown to act in a 
dominant–negative fashion and sensitize cells to IR, hydroxyurea, and UVR (Cliby et al., 
1998; Wright et al., 1998) and ATR was subsequently shown to be required for the UV-
induced inhibition of replicon initiation in both normal human dermal fibroblasts and in U2OS 
fibrosarcoma cells (Heffernan et al., 2002). Taken together, these studies support a model 
by which ATR acts as the primary sensor in the UV-induced intra-S checkpoint response. In 
this model, the ATR-ATRIP complex binds RPA coated ss-DNA produced when UVR-
induced photoproducts are encountered by the replicative polymerases while the helicase 
continues to unwind duplex DNA, and ATR kinase activity is essential for initiating the UV-
induced intra-S phase checkpoint response. There is evidence that upon binding of ATRIP 
and RPA, ATR is fully activated after autophosphorylation at Thr1989, allowing it to act on 
downstream targets, including the effector kinase, CHK1 (Liu et al., 2011; Nam et al., 2011). 
The alternative clamp loading protein complex Rad17-RFC is also thought to be involved 
with the ATR-dependent sensing step as it loads the heterotrimeric ring-clamp, Rad9-Rad1-
Hus1 (9-1-1) in response to UVR. Rad17 is itself a substrate for ATR kinase activity and 
seems to be required for downstream signaling of ATR (Zou et al., 2002). Interactions 
between TopBP1 (DNA topoisomerase binding protein 1), the 9-1-1 complex, and ATR-
ATRIP also seem to stimulate ATR kinase activity (Lee et al., 2007; Mordes et al., 2008). 
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The sensing functions of ATR and associated proteins are thought to propagate their 
signal via transducer kinases; primarily the checkpoint kinase protein CHK1, but also the 
structurally unrelated checkpoint kinase CHK2. The role of CHK1 in the S-phase checkpoint 
was examined in human lung cancer cell lines treated with the DNA damaging agent 
camptothecin after transient siRNA-mediated depletion of CHK1. It was found that CHK1 
was required for the camptothecin-induced S-phase arrest and that CHK1 also mediated the 
proteolysis of CDC25A in response to camptothecin or doxorubicin (Xiao et al., 2003). 
Furthermore, expression of a kinase-inactive CHK1 in U2OS cells or pharmacological 
inhibition of CHK1 in NHF1 attenuated the UVC-induced intra-S checkpoint response 
(Heffernan et al., 2002; Miao et al., 2003). Similarly, siRNA-mediated depletion of CHK1 in 
HeLa cells caused a reversal of the UVR-induced S-phase checkpoint when DNA fiber 
spreads were used to visualize active replication units (Chastain et al., 2006). Unlike CHK2, 
CHK1 is an essential gene whose deletion causes embryonic lethality (Takai et al., 2000). It 
was shown that CHK1 was phosphorylated on S317 and S345 in Hela or U2OS cells in an 
ATR-dependent manner following treatment with hydroxyurea or  UVR, and that these 
phosphorylations modulated the activity of CHK1 (Zhao and Piwnica-Worms, 2001). There is 
some suggestion that these ATR dependent phosphorylations may relieve inhibition by a C-
terminal inhibitory domain. Truncations of the C-terminal domain of Xenopus CHK1 
increases its kinase activity (Oe et al., 2001), while a rat isoform of CHK1 containing only the 
C-terminus inhibited CHK1 kinase activity in vitro (Shann and Hsu, 2001). Although there is 
evidence for crosstalk between ATR/ATM and CHK1/CHK2, these studies provided strong 
evidence for CHK1 as the primary mediator of the ATR-dependent inhibition of DNA 
synthesis in response to UVR. 
Initially, it was hypothesized that the ATR/CHK1 mediated S-phase checkpoint 
response was induced by the same mechanisms that are observed with the ATM-mediated 
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response to IR. Early studies did observe UV-induced degradation of CDC25A after 
irradiation with lethal dose of UVR (Goloudina et al., 2003; Hassepass et al., 2003; Mailand 
et al., 2000). There was speculation that the UV-induced inhibition of replicon initiation might 
be regulated at the pre-replication complex (pre-RC) and/or the MCM (minichromosome 
maintenance) helicase complex (Jares et al., 2000). The pre-RC forms at discrete origins of 
replication and requires the loading of the origin recognition complex (ORC), CTD6, CTD1, 
and the 6-subunit MCM. This pre-RC is “licensed” and subsequent firing of the origin is 
regulated by cyclin-dependent kinase phosphorylation of CDC6 and by DDK (DBF4-
dependent kinase comprised of CDC7/DBF4) phosphorylation of MCM subunits. It is 
thought that the DDK-dependent phosphorylation of MCM induces its helicase activity and 
facilitates unwinding of the duplex DNA at the origins, allowing loading of the DNA 
polymerase α-DNA primase complex. The S. pombe homolog of human CHK2, Cds1, 
phosphorylates the spDbf4 protein after treatment with hydroxyurea (Takeda et al., 2001). 
Similarly, in Xenopus extracts an etoposide-induced inhibition of replicon initiation was 
shown to be correlated with an abrogation of Dbf4 chromatin binding, thereby interfering 
with DDK activity (Costanzo et al., 2000). The involvement of the DDK complex in the UV-
induced inhibition of replicon initiation was further examined in NHF. Overexpression of Flag 
or Myc-tagged DBF4 attenuated the UVC-induced S-phase checkpoint response, but not 
that of IR (Heffernan et al., 2007). In addition, the sub-lethal dose of UVC used in this 
experiment had no influence on CDC25A levels. Similarly, CDC45 binding to chromatin was 
reduced in human non-small lung carcinoma cells following treatment with BPDE and the 
inhibition of DNA synthesis also found to be independent of CDC25A degradation (Liu et al., 
2006). Although the targets of CHK1 remain unidentified, these data indicated that the UV-
induced inhibition of replicon initiation does not depend on degradation of CDC25A as is 
seen with the IR-induced checkpoint response, but instead likely relies upon regulation of 
MCM loading to reduce origin firing. 
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Several other proteins have been identified as mediators of the ATR/CHK1 
dependent S-phase checkpoint. The human analog of the TIM (TIMELESS) protein was 
implicated in the circadian clock of Drosophila (Sehgal et al., 1994) and was proposed to 
have a similar function in mammals (Barnes et al., 2003). This protein has been shown to 
have UV-induced interactions with CHK1 and ATR/ATRIP (Unsal-Kacmaz et al., 2005) and 
to interact with MCM2 and DNA polymerase δ (Gotter et al., 2007). TIM and its 
heterodimeric binding partner, TIPIN (Timeless-interacting protein), were also shown to 
mediate UV-induced activation of CHK1 (Unsal-Kacmaz et al., 2007). Similarly, the protein 
CLASPIN was also implicated as an S-phase checkpoint mediator. CLASPIN was identified 
as a binding partner of CHK1 in Xenopus and extracts that were immuno-depleted of 
CLASPIN showed diminished CHK1 kinase activity (Kumagai and Dunphy, 2000). Analogs 
of TIM and TIPIN were termed the replication fork protection complex (RFPC) in yeast 
(Noguchi et al., 2004) and this complex has been proposed to protect stalled replication 
forks from collapse (Kaufmann, 2009; Smith-Roe et al., 2013). 
As previously mentioned, many of the proteins involved in the S-phase checkpoint 
are essential proteins. In addition, loss of several RFPC proteins has been shown to affect 
chromosomal integrity (Brown and Baltimore, 2000; Focarelli et al., 2009; Leman et al., 
2010; Smith-Roe et al., 2013). It has been suggested that RFPC proteins contribute not only 
to DNA damage induced S-phase checkpoint signaling, but that stabilization of the 
replication fork and preservation of chromosomal stability are separate functions of these 
proteins (Smith-Roe et al., 2013). DNA synthesis, chromosomal aberrations, and checkpoint 
signaling were examined in NHF cells depleted of RFPC proteins in the absence of 
exogenous DNA damaging agents. These experiments indicated a separation of checkpoint 
function from genome protection. For example, cells depleted of ATR showed a marked 
increase in chromosomal aberrations while cells depleted of CHK1 or TIPIN did not, despite 
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that depletion of TIPIN caused CHK1 activation. Furthermore, depletion of CHK1 inhibited 
DNA synthesis while depletion of ATR did not. In cells depleted of the various RFPC 
members, levels of CHK1 phosphorylation did not seem to correlate with the induction of 
chromosomal instability or survival in the absence of exogenous damage. These data show 
a complex interplay between RFPC members that participate in both checkpoint activation 
and in genome maintenance during normal replication.  
Summary of work in this dissertation 
The experimental work presented in this dissertation is divided between two 
chapters. The first details experiments designed to examine potential differences in 
biological outcomes in normal human dermal cells exposed to different wavelengths of UVR. 
This introduction has shown that different wavelengths of UVR induce differing types and 
proportions of DNA damage and that these aberrant DNA structures are induced by 
potentially different mechanisms. Furthermore, there is much debate about the relative 
contributions from different wavelengths in initiating and promoting mutagenesis and 
carcinogenesis. While much of the DNA damage responses have been characterized using 
UVC, comparatively fewer studies have been conducted utilizing wavelengths that model 
the more naturally occurring exposures to UVA and UVB. Furthermore, accurate dosimetry 
of specific types of DNA damage is not often included when reporting biological outcomes 
produced by exposure to UVR, making it difficult to accurately compare research from 
different laboratories. The research presented in Chapter 2 was designed to assess the 
biological outcomes of irradiating human dermal fibroblasts with UVR of different 
wavelengths and to do so using DNA damage dosimetry to provide a means by which to 
compare different irradiation sources. CPD and 6-4PP density were quantified and used as 
biomarkers of exposure following irradiation with UVA, UVB, or UVC. Comparing fluences of 
UVR that produced equal CPD densities, we assessed cytotoxicity induced by the three 
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wavelength ranges. Using the shortest (UVC) and the longest (UVA) wavelength range of 
UVR, we also characterized the activation of the intra-S phase checkpoint and compared 
the induced mutation frequencies. These experiments showed a striking similarity in the 
biological outcomes measured when exposure to various wavelengths were compared on 
the basis of CPD dosimetry. These results help to validate previous DNA damage response 
research that has utilized non-terrestrial UVC as a model for UVR exposure. In addition, this 
research highlights the importance of using DNA damage dosimetry or biomarkers to allow 
meaningful comparisons between UVR sources. 
The S-phase checkpoint response to UVR is described as a signaling cascade 
designed to recognize damaged DNA or abnormal DNA structures and halt or slow 
new/ongoing DNA replication, thereby reducing the chance that damaged DNA will be 
replicated prior to its repair. It is overwhelmingly purported to be a protective system and 
hypothesized to protect against UV-induced mutagenesis. The research presented in 
Chapter 3 was designed to test this hypothesis. Essential S-phase checkpoint components 
ATR and CHK1 were each depleted using siRNA, and the UV-induced mutation frequency 
at the HPRT locus was measured. Similarly, mutation frequency was measured after the 
CHK1 inhibitor TCS2312 was used to block CHK1 kinase signaling and abrogate the S-
phase checkpoint response to UVR. Results showed similar mutation frequencies in the 
irradiated populations with intact or with inactivated intra-S checkpoint responses. These 
findings challenge the belief that intra-S checkpoint activation helps prevent DNA damage-
induced mutations. 
  
 CHAPTER 2 
 
CYCLOBUTANE PYRIMIDINE DIMER DENSITY AS A PREDICTIVE BIOMARKER 
OF THE BIOLOGICAL EFFECTS OF ULTRAVIOLET RADIATION IN NORMAL 
HUMAN FIBROBLASTS1
 
 
Introduction 
Ultraviolet radiation (UVR) is an established environmental carcinogen that induces 
DNA damage in basal keratinocytes and melanocytes, potentially leading to cancer 
development (Gilchrest et al., 1999; Marrot and Meunier, 2008). The UVR spectrum is 
divided into three wavelength ranges: UVC (100-280 nm), UVB (280-315 nm) and UVA 
(315-400 nm). Wavelengths in the UVC range are absorbed by the Earth’s atmosphere; 
hence UVR reaching the surface of the planet consists of approximately 5-10% UVB and 
90-95% UVA. While the genotoxicity of UVB can be attributed to direct absorption of 
photons by DNA, the mechanism by which UVA causes genotoxicity is less clear. The 
predominant view has been that DNA does not readily absorb the energy from UVA and that 
endogenous photosensitizers are required to transfer the energy of UVA to DNA (Cadet et 
al., 2005; Mouret et al., 2006). However, experimental evidence that UVA can damage DNA 
directly has emerged (Jiang et al., 2009; Kuluncsics et al., 1999; Sage et al., 2012). 
Although the mechanism is in question, it is widely accepted that wavelengths above 300 
nm are capable of inducing the most common forms of DNA photodamage, including the 
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cyclobutane pyrimidine dimers (CPD) (Courdavault et al., 2004; Perdiz et al., 2000), and 6-4 
pyrimidine-pyrimidone photoproducts (6-4PP) (Besaratinia et al., 2011; Schuch et al., 2009). 
In addition, there is evidence that long wavelengths of UVR induce oxidative damage to 
DNA, possibly through the formation of singlet oxygen or other reactive oxygen species, 
resulting in oxidized bases, such as 8-oxo-7,8-dihydroguanine (8-oxo-dG) (Cadet et al., 
2005; Mouret et al., 2006).  
Much of the research examining the biological effects of UVR have utilized UVC, 
while comparatively fewer studies have been conducted with wavelengths that model the 
more naturally occurring exposures to UVA and UVB. The common use of UVC lamps can 
be attributed to their availability and low cost, the convenience of using a highly energetic 
source that allows short irradiation times, and the belief that the most abundant DNA lesion 
triggering UVR-induced responses are produced by UVA, UVB, and UVC. Indeed, there is 
evidence that wavelengths in the entire UVR spectrum induce CPD in the nuclear DNA of 
cultured cells (Besaratinia et al., 2011; Courdavault et al., 2004; Mouret et al., 2006; 
Snellman et al., 2003), and are mutagenic (Besaratinia et al., 2011; Enninga et al., 1986). 
Although there is little doubt that the CPD is the primary mutagenic lesion following 
exposure to UVC or UVB, the role of the CPD in UVA-induced mutagenesis is less clear 
(reviewed in (Runger and Kappes, 2008)), but cannot be neglected (Jiang et al., 2009; 
Kuluncsics et al., 1999; Sage et al., 2012).  
UVR damage to DNA has been shown to trigger various DNA damage responses, 
including repair, apoptosis, translesion synthesis (TLS), and the activation of cell cycle 
checkpoints. In most of these studies, UVC was used to characterize the responses to UVR, 
including activation of the intra-S checkpoint (Kaufmann et al., 1980b; Kaufmann and 
Cleaver, 1981). The intra-S checkpoint has been described as an active signaling system 
that recognizes UV-induced DNA damage and slows progression through S phase, thereby 
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reducing the probability that damaged DNA will be replicated, potentially lowering the risk for 
induced mutations (reviewed in (Kaufmann, 2009)). This checkpoint response to UVC was 
found to require the activity of checkpoint proteins ataxia telangiectasia and Rad3-related 
(ATR) kinase, and its substrate checkpoint kinase 1 (CHK1), to act on downstream targets 
to inhibit the firing of new origins of replication (Chastain et al., 2006; Heffernan et al., 2002; 
Miao et al., 2003) and to slow rates of DNA chain elongation (Petermann et al., 2006; Seiler 
et al., 2007; Unsal-Kacmaz et al., 2007). Comparatively less research has examined the 
intra-S checkpoint response to UVA and UVB, despite observations that the spectra of DNA 
damage induced by these wavelengths are not identical. At present, it is unclear which type 
of DNA damage is primarily responsible for UV activation of the intra-S checkpoint, although 
there is evidence that supports CPD, the most abundant, and 6-4PP as the UVC-induced 
lesions responsible for stalling of replication forks (Kaufmann, 2009).  
The main objective of the experiments reported here was to assess the biological 
outcomes of irradiating human dermal fibroblasts with three sources of UVR, each emitting 
different spectra of wavelengths. CPD and 6-4PP densities were quantified and used as 
biomarkers of exposure following irradiation with the UVA, UVB, or UVC sources. 
Comparing fluences of UV that produced equal CPD densities, we then assessed UV-
induced cytotoxicity for these three sources. Using the shortest (UVC) and the longest 
wavelength range of UVR (UVA), we also characterized the activation of the intra-S 
checkpoint and compared their mutagenic potential.  Our results suggest that in our model 
system the CPD burden efficiently predicts the cytotoxicity, activation of the intra-S 
checkpoint, and mutagenicity induced by UVR. 
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Results 
Dosimetry curves 
Immunoblotting was first used to assess the induction of CPD in NHF1 cells exposed 
to UVA, UVB, or UVC (Figure 2.1). As expected, UVC was the most efficient UVR source, 
causing the formation of approximately 34 CPD per Mb of DNA for each 1 J/m2 increase in 
incident fluence (slope of the fluence-response curve). UVB and UVA also produced CPD in 
a fluence dependent manner, although at much lower efficiencies (121 and 9.4 CPD/Mb per 
kJ/m2, respectively). These dosimetry curves were used in all subsequent experiments to 
select exposures to different UVR sources in order to compare their biological effects on an 
equal CPD density basis. 
Later experiments used DNA from independently irradiated NHF1 cultures and RIA 
to determine the UVR induction of both CPD and 6-4PP in the same DNA samples (Figure 
2.2). The observed relative densities of 6-4PP per 100 CPD were 14, 11, and 7 for the UVC, 
UVB, and UVA sources, respectively. UVC was marginally more efficient at producing 6-4PP 
than UVB, but the difference did not reach statistical significance (p=0.09). UVC was 
significantly more efficient at producing 6-4PP than irradiation with the UVA source used in 
these experiments (p=0.04). DNA from irradiated cells was also analyzed for the presence 
of 8-oxo-dG, the most common oxidative DNA lesion; 8-oxo-dG was not formed in a fluence 
responsive manner and was not produced in levels appreciably higher than background 
(Table 2.1).  
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Figure 2.1 CPD dosimetry curves for NHF1 exposed to a) UVC (open diamonds) and b) 
UVB (open squares) or UVA (closed cicles). CPD densities determined by immunoblotting, 
using standard curves prepared with irradiated calf-thymus DNA with known CPD densities, 
which were independently determined by RIA (each point represents the mean of 2-4 
measurements; error bars indicate SEM). 
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Figure 2.2 6-4PP dosimetry curves. Dose response curves for the formation of 6-4 
pyrimidine-pyrimidone photoproduct in NHF1 exposed to UVA (closed circles), UVB (open 
squares) or UVC (open diamonds) as a function of CPD density. The 6-4PP density 
produced by UVC was statistically different than that produced by UVA (p=0.04 by linear 
regression analysis). Both lesions were quantified in each sample by RIA (n=3-4, mean ± 
SEM). 
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8-oxo-dG/106 
dG Experiment 1 Experiment 2 Experiment 3 
background 
calf thymus 
DNA1 
0.85 0.85 0.68 
background 
calf thymus 
DNA2 
None determined 2.15 0.82 
% recovery of 
8-oxo-dG 
spiked calf  
thymus DNA 
101% 106% 97% 
CPD/Mb UVA UVC UVA UVC UVA UVC 
0.0 1.08  0.71 0.62 0.58 0.58 
122.1 1.22  2.20 3.43 1.26 1.16 
259.4 1.30 
 
2.28 0.69 1.29 1.72 
328.0  1.13     
396.6 1.64  1.53 0.64 0.85 2.58 
396.6 1.86      
 
Table 2.1 Quantification of 8-oxo-dG in NHF1 cells exposed to UVA or UVC. LC/MS/MS 
was used to quantify 8-oxo-dG levels in NHF1 cells exposed to UVA (0, 14.7, 29.2, or 43.7 
kJ/m2) or UVC (0, 4, 8, 10, or 12 J/m2). Fluences were chosen to produce equal CPD 
densities. Assay was performed by Biomarker Mass Spectrometry Core Facility, Center for 
Environmental Health and Susceptibility (CEHS), University of North Carolina, Chapel Hill as 
described in Boysen, G. et al. (2010). J. Chromatogr. B. Analyt Technol. Biomed. Life. 
Sci.878, 375-380. 
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Cytotoxicity 
Figure 2.3 shows the cytotoxicity curves for UVA, UVB and UVC, expressed as the 
percent survival relative to CPD burden. As expected, irradiation with each source of UVR 
produced a dose-dependent decrease in survival. The increase in fluences required to 
decrease the surviving fraction from 100% to 37% (D0) were 16.8 kJ/m2, 2.0 kJ/m2, and 5.5 
J/m2, or 159, 236, and 190 CPD/Mb, for UVA, UVB and UVC, respectively. When expressed 
in terms of the CPD density, UVB and UVC caused similar toxicity profiles (p=0.41 for the 
comparison of D0 values); while the UVA cytotoxicity curve did not overlap with those for 
UVB and UVC (p<0.005 for both UVA vs. UVB and UVA vs. UVC, linear regression 
analysis), the differences in the estimated D0 did not reach statistical significance (UVA vs. 
UVB p=0.17, UVA vs. UVC p=0.23). 
Activation of the intra-S phase checkpoint 
The activation of the intra-S phase checkpoint was examined in NHF1 cells irradiated 
with either the UVA or the UVC lamps. Should there be significant differences in the 
biological responses to DNA damage induced by different wavelengths of UVR, they would 
most likely be observed between the two irradiation sources emitting at the opposite ends of 
the UV spectrum. Phosphorylation of CHK1 at serine 345 is commonly used as an index of 
DNA-damage-induced activation of the intra-S checkpoint. Based on the dosimetry curves 
illustrated in Figure 2.1, NHF1 cells were irradiated with fluences of UVA or UVC calculated 
to produce equal CPD densities. Cells were harvested 45 min post-irradiation and protein 
extracts were probed for P-CHK1 (S345), total CHK1, and ACTIN (Figure 2.4a). Figure 
2.4b summarizes the quantification by densitometry of immunoblot signals from three 
independent experiments. The ratios of P-CHK1 to total CHK1 were normalized to the same  
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Figure 2.3 Cytotoxicity as a function of CPD burden for NHF1 exposed to UVA, UVB, 
or UVC. Cytotoxicity as a function of CPD burden for NHF1 exposed to UVA (closed 
circles), UVB (open squares), or UVC (open diamonds). Percent survival measured by [3H]-
thymidine incorporation 72 h post-irradiation as compared to the unirradiated sham (n=2-4, 
mean ± SEM). There was no statistical difference between the D0 values expressed in terms 
of CPD density (Wald test p-values were 0.17 for UVA vs. UVB, 0.23 for UVA vs. UVC, and 
0.41 for UVB vs. UVC). 
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Figure 2.4 CHK1 phosphorylation in NHF1 exposed to UVA or UVC. Fluences of UVA 
or UVC were chosen so as to produce equivalent CPD burdens. a) Immunoblot showing P-
CHK1 (S345), total CHK1, and ACTIN. b) Quantification of immunoblots (n=3) by 
densitometry ± SEM. Densitometry values were normalized to the highest ratio of P-
CHK1:total CHK1 in each experiment. The normalized ratios of P-CHK1 to total CHK1 
produced by the UVA source were not statistically different (Wilcoxon rank-sum test) from 
those produced by UVC at equal CPD densities. 
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ratio determined for the sample with the highest signal in each experiment and plotted 
against CPD/Mb. Both UVA and UVC induced CHK1 phosphorylation at S345 as the CPD 
burden increased and no statistically significant differences were observed in the magnitude 
of the responses induced by the two UVR sources.  
Intra-S checkpoint activation was also functionally assessed by velocity 
sedimentation analyses of nascent DNA pulse-labeled with [3H]-thymidine. This technique 
was used to determine the size distribution of newly replicated DNA and to examine how 
exposures to UVA or UVC affected that distribution. First, low fluences of UVR were used to 
examine the selective inhibition of synthesis of low molecular weight (MW), origin-proximal 
nascent DNA. NHF1 cells were exposed to 3.8 kJ/m2 UVA or 1 J/m2 UVC, fluences shown to 
result in similar CPD burdens (Figure 2.1) and cause minimal cytotoxicity (Figure 2.3, 86% 
and 78% survival, respectively). After irradiation, cells were incubated for 30 min, pulse-
labeled with [3H]-thymidine for 15 min, harvested and lysed on top of alkaline sucrose 
gradients (Figure 2.5). Low fluences of UVC have been previously shown to selectively 
inhibit the production of small MW DNA intermediates that initiated DNA synthesis during the 
30 min incubation after irradiation or within the 15 min pulse-labeling with [3H]-thymidine 
(Kaufmann et al., 1980a; Kaufmann and Cleaver, 1981) and that this inhibition is dependent 
on signaling by the checkpoint kinases ATR and CHK1 (Heffernan et al., 2002; Miao et al., 
2003). As a functional biomarker for the inhibition of replicon initiation, reduction in labeling 
of small MW nascent DNA was used to assess activation of the intra-S phase checkpoint. 
The observed inhibition was 34 ± 6% after a low fluence of UVA (3.8 kJ/m2), by comparison 
to the matched sham control, and 40 ± 7% after 1 J/m2 UVC.  
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Figure 2.5 Inhibition of replicon initiation by UVC or UVA. Velocity sedimentation 
analysis of nascent DNA from NHF1 cells exposed to low fluences of a) UVC (sham-closed 
diamonds or 1 J/m2-open squares) or b) UVA (sham-closed diamonds or 3.8 kJ/m2-open 
squares). Fluences were chosen so as to induce equal CPD densities (~19 CPD/Mb). 
Inhibition of small MW DNA, measured from the area under the curve between the two 
arrows, was 34% ± 6% of sham (UVA) and 40% ± 7% (UVC) n=3 (mean ± SEM), and these 
values were not statistically different (p=0.4, Wilcoxon rank-sum test). 
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Velocity sedimentation can also be used to assess the effect of irradiation on DNA 
strand growth by examining the abundance of labeled DNA intermediates of high MW. 
Fluences of UVR higher than those used to document the inhibition of replicon initiation also 
inhibit the production of multi-replicon-sized DNA intermediates in a dose-dependent 
manner. Once again, fluences were chosen to cause similar CPD densities in cells irradiated 
with UVA (Figure 2.6a) or UVC (Figure 2.6b). Figure 2.6c summarizes the data from 
several experiments and shows that DNA strand growth was inhibited as the CPD burden 
increased, regardless of the source used to irradiate the fibroblasts. 
Mutagenesis 
UVR-induced mutation frequencies at the HPRT locus were measured in NHF1 cells 
exposed to either UVA or UVC fluences inducing similar densities of CPD. Colonies 
resistant to 6-thioguanine were counted as mutants lacking functional HPRT and the 
mutation frequency expressed per 106 surviving cells (Figure 2.7). Mutagenicity results from 
one experiment with XPV fibroblasts are included as a positive control, as these cells lack 
the translesion synthesis DNA polymerase eta and are known to be hypermutable in 
response to UVR (Bassett et al., 2004). Both the lower fluence (4 J/m2) and the higher 
fluence (7.5 J/m2) of UVC induced mutation frequencies above the matched sham-irradiated 
controls (p=0.03 and 0.01 respectively). After normalizing for CPD burden, no significant 
difference was detected in the frequencies of induced mutations between NHF1 cells 
exposed to UVA or UVC.  
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Figure 2.6 Inhibition of DNA strand growth by UVC or UVA. Representative velocity 
sedimentation analysis of nascent DNA from NHF1 cells exposed to high fluences of a) UVC 
(5, 7.5, 8, 10, or 12 J/m2) or b) UVA (18.3, 27.4, 29.2, 36.5, or 41.6 kJ/m2). Fluences were 
chosen to induce equal CPD densities (156, 242, 259, 328, or 397 CPD/Mb, respectively). 
c) Inhibition of DNA strand growth (calculated from the area under curve between the two 
arrows as compared to sham irradiated) is shown as a function of CPD burden for NHF1 
exposed to UVA (closed circles) or UVC (open diamonds). There was no statistical 
difference in the % inhibition of DNA strand growth by UVA or UVC (linear regression 
analysis, p=0.59). 
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Figure 2.7 UVA or UVC-induced mutation frequency at the HPRT locus. HPRT mutation 
frequency in 2359XPV cells (closed triangles, n=1) or NHF1 exposed to UVA (closed circles, 
n=4) or UVC (open diamonds, n=4) expressed as mutants per 106 surviving cells ± SEM. 
The mutation frequency induced by UVA was not statistically different from that induced by 
UVC (p=0.2 and 0.69 for 122 or 242 CPD/Mb respectively, Wilcoxon rank-sum test). 
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Discussion 
The health effects of prolonged skin exposures to the sun have been connected 
mechanistically to the cellular DNA damage induced by UVR. However, there is still 
controversy over which wavelengths are most dangerous and whether or not exposure 
primarily to UVA (for example through tanning beds) carries the same risks as sunlight, 
which also includes wavelengths within the UVB range. The properties of different 
wavelengths of UVR, in particular skin penetration and efficiency of inducing different types 
of cellular damage (including those triggering inflammation) have made the detailed 
investigation of this complex issue quite difficult. 
This study focused specifically on DNA damage caused by UVR in cultured human 
fibroblasts and the attendant biological responses, both shortly after irradiation (activation of 
the intra-S checkpoint, inhibition of DNA synthesis), as well as the resulting cytotoxicity and 
frequency of HPRT mutations in the surviving populations. Biological effects produced by 
UVR cannot be compared on the basis of the incident fluence alone, which are often 
measured at a single wavelength, while the source spectral profiles can vary widely. 
Therefore, in order to compare biological responses to the UVR sources used in this study, 
DNA damage dosimetry curves for CPD (Figure 2.1) and 6-4PP (Figure 2.2) were 
produced. CPD densities per J/m2 indicated that UVC was approximately 284 and 3654 
times more efficient than UVB and UVA, respectively, in producing this type of DNA lesion. It 
is well established that short wavelength UVR produces CPD in either irradiated cells or 
purified DNA in solution more efficiently than long wavelength UVR (Clingen et al., 1995; 
Douki et al., 1999; Enninga et al., 1986; Kuluncsics et al., 1999). The relative amounts of 
UVA-induced CPD reported here are higher than other reported values, but this is not 
surprising given that the lamp used emits ~5.7% of its radiant energy in the UVB range. 
UVC was also more efficient in producing 6-4PP; after normalization to the CPD density in 
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the same sample, the density of 6-4 PP per CPD was 1.3 and 2 times higher in DNA from 
cells exposed to UVC than in those exposed to the UVB and UVA sources, respectively 
(Figure 2.2). This relative 6-4PP production is similar to values reported in human dermal 
fibroblasts, where UVC induced 1.4 times more 6-4PP per CPD than did irradiation with a 
narrow-band UVB source (Clingen et al., 1995); but, it is lower than observed in DNA from 
mouse embryonic fibroblasts, where UVC produced 5.4 times more 6-4PP per CPD than did 
a monochromatic source of UVB (305nm) (Besaratinia et al., 2011). It is also expected that 
the 6-4PP density measured in NHF1 exposed to the UVA lamp was produced by UVB 
wavelengths emitted by this source, as it is generally believed that 6-4PP are not produced 
by wavelengths greater than 310nm (Besaratinia et al., 2011; Douki et al., 2003; Pfeifer and 
Besaratinia, 2012). 
Survival curves generated using the UVA, UVB, and UVC lamps and constructed 
against CPD densities suggest that this type of DNA damage was primarily responsible for 
the induced cytotoxicity, regardless of the radiation source (Figure 2.3). The estimated D0 
values were not statistically different, and the CPD densities correlated better with the 
overall survival than the 6-4PP densities; although 8-oxo-dG was not detected above 
background, it is possible that the slightly reduced survival observed after UVA irradiation 
could be due to oxidative damage to other cellular components. Other studies have reported 
a wavelength-dependent increase in cytotoxicity, with longer wavelengths causing higher 
inactivation of colony formation, when compared on the basis of equivalent dimer densities 
(Enninga et al., 1986), or that cytotoxicity in cultured cells irradiated with UVC or UVB 
correlated best with the 6-4PP density (Clingen et al., 1995). The study reported here, as 
well as those cited above used the same narrow-band UVB source and were performed with 
normal human dermal fibroblasts; so the differences described are not likely to be due to 
different cell types or UVR sources.  
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CPD density was well correlated with the activation of the intra-S checkpoint in 
fibroblasts exposed to UVA and UVC. Phosphorylation of CHK1 at S345 (Figure 2.4), 
inhibition of replicon initiation (Figure 2.5), and inhibition of DNA strand growth (Figure 2.6) 
were all adequately described by CPD density. The observation that CPD density, and not 
the 6-4PP density, correlated best with these endpoints is consistent with a model that the 
CPD, as the most abundant lesion induced by UVR, is the primary UV-induced DNA 
damage encountered by DNA replication forks, thus initially creating a majority of genome 
sites where the activation of ATR/CHK1 takes place to trigger the intra-S checkpoint 
responses. 
The time course of inhibition of DNA synthesis and the lesion repair kinetics in 
human fibroblasts have been used to suggest that CPD were not likely to be predominantly 
responsible for intra-S phase checkpoint activation. The maximal CHK1 phosphorylation 
signal and inhibition of DNA synthesis are both reported to occur 45-120 min following UVC 
irradiation and to recover to basal levels within 6 h post-irradiation (Chen et al., 2009; 
Kaufmann and Cleaver, 1981). While significant numbers of CPD remain after DNA 
synthesis has recovered, the kinetics of 6-4PP repair closely match this time course, with 
more than 80% of the 6-4PP being removed within 6 h post–irradiation (Courdavault et al., 
2005). The data presented here, however, are more consistent with the CPD being the 
lesion primarily responsible for checkpoint activation, and that recovery of DNA synthesis 
occurs even in the presence of persisting CPD.  This interpretation is supported by data 
showing that UV-induced γ-H2AX foci, also a marker of ATR activation, are formed within 
the first hour post-irradiation, continue to accumulate 48 h post irradiation, and are reduced 
by 50% upon CPD photoreactivation (Garinis et al., 2005; Ward and Chen, 2001). Thus, it is 
plausible that the decay in checkpoint signaling is related not to repair of the less frequent 6-
4PP (although it could be a contributing factor), but to the efficiency of translesion synthesis 
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(TLS) across UV-induced CPD; indeed, TLS-defective XP-V fibroblasts display delayed 
intra-S phase checkpoint recovery following UV-irradiation (Bi et al., 2005) despite having 
normal rates of nucleotide excision repair (Boyer et al., 1990; Tung et al., 1996). 
Other studies have examined the influence of long wavelength UVR on the intra-S 
checkpoint. Irradiation of SV40-transformed normal human fibroblasts and AT-fibroblasts 
showed that both displayed inhibition of DNA synthesis following irradiation with UVA or 
UVC (Girard et al., 2008). Treatment with 5 mM caffeine (an ATM and ATR inhibitor) 
abrogated this inhibition in both cell types following irradiation with UVC but not with UVA, 
suggesting that the ATR/CHK1 pathway is dispensable to UVA-induced inhibition of DNA 
synthesis. However, these studies also reported a relatively low production of CPD (less 
than 2 TT CPD/Mb) at UVA fluences that caused both significant cytotoxicity and inhibition 
of DNA synthesis; these findings led the authors to conclude that DNA damage (TT CPD, 8-
oxo-dG, or strand breaks) was not contributing to inhibition of DNA synthesis despite 
evidence that CHK1 was being activated. Instead, they suggested that the inhibition of DNA 
synthesis could be explained by UVA-induced ROS causing oxidation of replication proteins. 
Such an effect is less likely in the studies reported here, since our UVA irradiation conditions 
appear to have produced significantly lower levels of UVA-induced ROS (Table 2.1).  
No differences in mutation frequencies at the HPRT locus were observed in NHF1 
cells irradiated with UVA or UVC when compared on an equal CPD basis (Figure 2.7). 
These data suggest that in this model system, the CPD is the UVR-induced photolesion 
predominantly contributing to mutagenesis. It is also noteworthy that formation of 8-oxo-dG 
was not detectable (Table 2.1) at levels above background, suggesting that oxidative 
damage to DNA did not likely contribute significantly to UVR-induced mutagenesis. The data 
presented here are at odds with other findings examining the effect of UVR wavelength on 
mutagenesis. Human fibroblasts irradiated with longer wavelengths of UVR displayed higher 
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mutation frequencies than those irradiated with short wavelength UVR when compared on 
the basis of equal T4 endonuclease sensitive sites, a common marker for CPD (Enninga et 
al., 1986). Authors suggested that either long wavelength UVR produced additional DNA 
damage that contributed to mutagenesis, or interfered with the efficient repair or lesion 
bypass of CPD. Approximately two-fold higher mutation frequencies were observed in a 
shuttle vector carried by human embryonic kidney cells when cultures were irradiated with 
equitoxic fluences of UVA as compared to UVB (Robert et al., 1996b). Mutation frequency in 
primary neonatal human fibroblasts was also higher in cells irradiated with UVA as 
compared to roughly equitoxic fluences of UVB (Kappes et al., 2006), but quantitative 
toxicity and dosimetry data were not provided. Each of these studies relied upon the use of 
different UVR sources, possibly accounting for some of the divergence in the results. 
Furthermore, the lack of dosimetry data in some cases makes comparisons between the 
studies difficult, and emphasizes the utility of quantitative DNA damage markers. 
The observation of similar mutation frequencies in NHF1 irradiated with UVA and 
UVC are consistent with other research examining the mutation spectrum induced by 
different wavelengths of UVR. The C:G→T:A transition and the CC:GG→TT:AA tandem 
mutations are considered UV signatures arising from replication past CPD and 6-4PP 
(Ziegler et al., 1993).  Sequencing of the HPRT gene in primary neonatal fibroblasts showed 
that C:G→T:A transitions were by far the most abundant UV-induced mutation induced by 
either UVA or UVB, and that these tended to occur in pyrimidine rich hotspots (Kappes et 
al., 2006). In addition, most of these mutational hotspots were shared by cells irradiated with 
UVA or UVB, suggesting that these mutations were formed by a common mechanism. 
Similarly, C:G→T:A transitions at dipyrimidine sites were also the most common base pair 
change found in mutants isolated from the epidermis of transgenic mice harboring λ-phage-
based lacZ mutational reporter genes after irradiation with UVA or UVB (Ikehata et al., 
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2008). These findings support the conclusion that the CPD is the primary lesion associated 
with UVR-induced mutagenesis.  
One limitation of the current analysis is the use of dermal fibroblasts that are not the 
target of UVR carcinogenesis in skin. We have compared the effects of UVC, UVB and UVA 
on human dermal melanocytes. We found that melanocytes displayed levels of 
phosphorylation of checkpoint kinases in response to UVR similar to fibroblasts (see 
Supplemental Material Figure S2.1). Normal human melanocytes were also found to repair 
CPD and 6-4PP with kinetics similar to fibroblasts (see Supplemental Material Figure S2.2 
and (Gaddameedhi et al., 2010)). Thus, the radiobiological responses reported here for 
fibroblasts are likely to hold true for melanocytes.  
Taken together, the results described in this paper constitute strong evidence that 
CPD density is the most predictive biomarker for the biological effects derived from UVR 
exposure. We recognize that the broad-spectrum UVA lamp used in this study emits ~5.7% 
UVB wavelengths (based on manufacturer’s spectral output curves), but emphasize that this 
percentage is similar to that present in natural sunlight and that similar UVA sources are 
increasingly utilized in biological research. This UVB representation is expected to have 
contributed to the abundance and relative proportions of CPD and 6-4PP, and thus also to 
the biological responses measured in the fibroblasts irradiated with the UVA lamp. 
Therefore, the importance of including quantitative DNA damage dosimetry to studies 
examining UVR-induced biological responses cannot be emphasized enough. 
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Materials and methods 
Cell culture  
The normal human fibroblast cell line NHF1-hTERT was derived from neonatal 
foreskin fibroblasts (Boyer et al., 1991) and immortalized by ectopic expression of the 
catalytic subunit of human telomerase (Heffernan et al., 2002). The xeroderma 
pigmentosum variant (XPV) cell line GM02359-hTERT (XP115L0) was derived in the 
laboratory of Dr. Roger A. Shultz (University of Texas Southwestern Medical Center, Dallas, 
TX; (Ouellette et al., 2000)) and clone 1B (Cordeiro-Stone et al., 2002) was compared with 
NHF1 in the studies reported here. Cells were cultured in Minimum Essential Medium 
(MEM) supplemented with 2 mM L-glutamine and 10% fetal calf serum. GM02359-hTERT 
cells were additionally supplemented with 1x MEM non-essential amino acids (Gibco). All 
cell cultures were maintained at 37°C in humidified 95% air and 5% CO2. 
Irradiation 
Cells were rinsed in phosphate buffered saline (PBS) prior to irradiation and all cell 
culture plates were irradiated with lids removed. See Figure S2.3 for the relative emission 
spectra for each lamp used. UVC irradiation was performed with a germicidal fluorescent 
lamp (Sylvania G8T5, 90% emission at 254 nm). UVB irradiations were performed with two 
Philips TL20W/01 NB-UVB fluorescent lamps emitting between 300 and 315 nm, with a 
maximum emission at 312 nm. UVA irradiations were performed with four Houvalite 
F20T12BL/HO PUVA lamps, emitting between 300 and 400 nm, with a maximum emission 
at 350 nm. UVC irradiations were performed with no liquid in the plates, while PBS was 
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used to cover the cultures during UVB and UVA exposures (as detailed below). Sham 
irradiated plates were handled the same way minus the exposure to UVR. These control 
plates were covered with aluminum foil and placed in the irradiation chamber along with 
those exposed to the highest fluence used in the experiment. Lamp irradiance was 
measured using a UVX Digital Radiometer (UVP, LLC) and the following sensors: UVX-25  
(250-290nm range, calibrated at 254 nm), UVX-31 (280-340 nm range, calibrated at 310 
nm) and UVX-36 (335-380 nm range, calibrated at 365 nm).  
Cytoxicity 
UVR-induced inhibition of [3H]-thymidine incorporation was measured as an index of 
cytotoxicity, as described previously (Kaufmann et al., 2003; Yamada et al., 2000). This 
short-term assay for inhibition of cell proliferation yields results in close agreement with 
those based on reduction of efficiency of colony formation (Kaufmann et al., 2003). 
Logarithmically growing cells were seeded in 6-well plates at 1000 cells per well. The 
following day, cells were rinsed with PBS and irradiated with increasing fluences of the 
specified UVR sources; 500 µL or 1 mL PBS were used to cover cells in each well during 
irradiation with UVB or UVA, respectively. Approximately 72 h post-irradiation, cells were 
pulse labeled for 60 min at 37°C in medium containing 2 μCi/mL [3H]-thymidine. Afterwards, 
the plates were placed on ice and the wells rinsed 2x with cold PBS. Cells were then fixed in 
5% trichloroacetic acid (TCA) for 30 min and rinsed 2x with 5% TCA and 2x with 95% 
ethanol. Fixed cells were allowed to dry overnight and then dissolved for 1 h in 1 mL of 0.3 
M sodium hydroxide. Equal volumes of solubilized cells were analyzed by liquid scintillation 
counting. 
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Immuno-slot blot quantification of CPD 
Cell cultures were irradiated in 10-cm dishes after rinsing and removing the liquid 
from the plates (UVC), or while covered with 2 mL (UVB) or 6 mL (UVA) PBS. DNA from 
irradiated cells was purified using a Qiagen DNeasy Blood and Tissue kit, using RNase A to 
remove RNA in the samples and CPD quantified as published (Karbaschi et al., 2012). After 
denaturation at 100°C for 10 min, 200 ng of DNA was combined with an equal volume of 2 
M ammonium acetate and placed on ice. Each DNA sample was spotted onto a 
nitrocellulose membrane (equilibrated in 1 M ammonium acetate) in triplicate, using a 
Minifold slot-blot manifold (Schleicher & Shuell). Membranes were then washed in 5x Saline 
Sodium-Citrate (SSC) buffer for 15 min in a 37°C water bath, and dried in a vacuum oven for 
30 min at 80°C. After blocking in 5% powdered milk in TBST (0.5% Tween-20, 10 mM Tris-
HCl, 10 mM NaCl, pH 7.4), membranes were probed with mouse anti-CPD antibody 
(Cosmo-Bio, NMDND001). Following secondary antibody application (HRP-conjugated, GE 
Healthcare), enhanced chemiluminescence (ECL) was used to detect on film the antibody-
dependent signal from each DNA band. Densitometry of film bands was performed using an 
Alpha Innotech Fluor-Chem HD2. Each membrane contained a standard curve prepared 
from UVC-irradiated calf thymus DNA in which the CPD density had previously been 
determined by radioimmunoassay (RIA). 
Radioimmunoassay 
DNA damage was quantified using RIA. RIA is a competitive binding assay between 
radiolabeled DNA and sample DNA for antisera raised against UV-irradiated DNA. DNA 
damage frequencies in samples used for the standard curve were determined using HPLC 
tandem mass spectrometry (Thierry Douki, CEA, Grenoble). These details, as well as those 
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concerning the specificities of the RIAs and standards used for quantification, are described 
in (Berton and Mitchell, 2012; Mitchell, 1996; Mitchell, 2006). 
Western blotting and antibodies 
Cells were harvested by trypsinization 1 h after irradiation, pelleted and flash frozen 
in liquid nitrogen. Cell pellets were resuspended in urea lysis buffer (8 M urea, 5 M 
NaH2PO4, 1 M Tris-HCl pH 8) for 30 min on ice and then clarified by centrifugation at 16000 
x g and 4°C. Protein concentrations were determined using the Bio-Rad Protein Assay kit. 
Protein lysates were combined with equal volumes of loading buffer (125 mM Tris pH 6.8, 
20% glycerol, 10% β-mercaptoethanol, 4% sodium dodecyl sulfate, 0.05% bromo-phenol 
blue) and equal amounts of protein were loaded onto BioRad Criterion-TGX 4-15% gradient 
gels (run for approximately 150-200 V for 2-4 h). Size-separated proteins were transferred 
(100 mA, overnight) onto a nitrocellulose membrane, and blocked in 5% powdered milk in 
TBST. The following antibodies were used: rabbit anti-P-CHK1 S345 (2348s Cell Signaling), 
mouse anti-CHK1 (SC-8408, Santa Cruz), goat anti-ACTIN (SC-1616, Santa Cruz). 
Following incubation with secondary antibody (HRP-conjugated, GE Healthcare), bands 
were visualized on film by ECL. Densitometry of film bands was performed using an Alpha 
Innotech Fluor-Chem HD2. 
Velocity sedimentation 
The steady-state size distribution of nascent DNA was determined 45 min after UV 
irradiation by centrifugation in an alkaline sucrose density gradient as previously described 
(Day et al., 2011; Kaufmann et al., 1980b). Cells were uniformly pre-labeled by incubation 
with 5-10 nCi/mL [14C]-thymidine for at least 36 h during logarithmic growth. Medium 
containing [14C]-thymidine was removed overnight and cells treated the following day. Cells 
for alkaline sucrose gradient experiments were grown in 60 mm dishes and covered with 2 
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mL PBS during UVA irradiations. After UV-irradiation, cells were incubated for 30 min in 
reserved medium and then pulse-labeled with 25 µCi/mL [3H]-thymidine for 15 min. Cells 
were washed, then scraped on ice into 0.1 M NaCl, 0.01 M EDTA (pH 8) and 0.5 ml added 
to an equal volume of lysis buffer (1 M NaOH, 0.02 M EDTA) on top of an alkaline sucrose 
gradient (5-20% sucrose in 0.4 M NaOH, 2 M NaCl, 0.01 M EDTA). These gradients were 
left under fluorescent lighting for 45 min and then centrifuged in a Beckman SW32Ti rotor at 
25000 rpm and 20°C for 5 h. Gradients were fractioned into equal volumes through a hole 
punched in the bottom of the centrifuge tube and acid-precipitable material filtered onto 
glass microfiber filters (Whatman GF/C 24mm), which were then analyzed by liquid 
scintillation counting. All experiments included cells pre-labeled with [14C]-thymidine, but not 
pulse-labeled with [3H]-thymidine, which were used to measure the 14C CPM values 
detected in the 3H channel (spillover) during liquid scintillation counting. Normalized 3H CPM 
were the counts in each fraction detected in the 3H channel, corrected for the 14C spillover, 
and divided by the total 14C in the gradient (proportional to the number of cells analyzed). 
HAT selection 
Cells used for mutagenesis experiments were preselected for functional HPRT by 
expanding cultures for 10-14 days in medium supplemented with 1 x HAT (Bassett et al., 
2004). The 100x lyophilized HAT solution contains 10 mM sodium hypoxanthine, 40 M 
aminopterin, and 1.6 mM thymidine. Aliquots of HAT selected cells were frozen and stored 
and a new aliquot was used for every HPRT mutagenesis experiment. Cell cultures were 
expanded in normal medium without HAT for 10-14 days prior to mutagenesis experiments.  
Mutagenesis 
Cells were plated at 5x105 per 10-cm dish (2 dishes per treatment) and irradiated the 
following day. Cell cultures were irradiated after rinsing and removing the liquid from the 
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plates (UVC), or while covered with 6 mL PBS (UVA). These cultures were maintained in 
logarithmic growth for 4-6 population doublings prior to selection. HPRT mutants were 
selected by plating 4x104 cells per 10-cm dish (55 dishes per treatment) in medium 
containing 40 µM 6-thioguanine. Colony forming efficiency was determined at the time of 
mutant selection by plating 400 cells per dish in medium lacking 6-thioguanine. After 2 
weeks, colonies were fixed in 3:1 methanol:acetic acid and stained with 0.05% crystal violet. 
Colonies with more than 50 cells were counted. Mutation frequencies were calculated from 
the number of plates without any mutant colonies, using the Poisson distribution as follows: 
[-ln (number of plates without 6-thioguanine resistant colonies/total number of 
plates)]/[(number of cells plated for selection) x (colony-forming efficiency at time of 
selection)]. 
Statistical methods 
Statistical comparisons were performed in order to determine whether 6-4PP density, 
cytotoxicity, CHK1 phosphorylation, inhibition of replicon initiation, inhibition of DNA strand 
growth, and mutagenicity varied significantly between different sources of ultraviolet 
radiation. The linear regression model was used to carry out the data analysis for estimating 
various parameters of interest with appropriate 95% confidence intervals, and hypothesis 
testing. Specifically, the linear model was used to model the density of 6-4PP and the 
inhibition of DNA strand growth as response variables with the density of CPD, the radiation 
source, and their interactions as covariates. Wald statistics were used to determine the 
statistical significance of the comparisons. The Wilcoxon rank sum test was used to do the 
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 group-wise comparison at different CPD levels at various sources of UVR for cell survival 
percentage, normalized ratios of P-CHK1 to total CHK1, inhibition of replicon initiation, and 
the mutation frequencies. Exact test statistics were used to determine the statistical 
significance of the comparisons. All statistical analyses were performed using SAS 9.3 (SAS 
Institute Inc., Cary, NC). 
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Supplemental material 
 
 
Figure S2.1 Activation of the intra-S checkpoint by UV-induced DNA damage in 
normal human melanocytes. Activation of checkpoint kinases by UVR-induced DNA 
damage in normal human melanocytes. Lightly pigmented NHM4+TERT and heavily 
pigmented NHM28+TERT melanocytes were sham-treated or irradiated with UVC, UVB (a 
broad-band source emitting 280-370 nm, peak emission at 316 nm) or UVA using fluences 
pre-determined to induce equal CPD densities in human fibroblasts. After 30-min incubation, 
cells were harvested for immunoblot analysis of the phosphorylation status of ATM (P-ATM, 
Cell Signaling 4526; ATM, Santa Cruz SC-7230) and CHK1. P-ATM/ATM and P-Chk1/Chk1 
ratios were normalized to the sham-treated control. The lower ratios determined for the 
M28+hTERT melanocytes are expected to be due to an attenuation of the DNA damage 
burden in these heavily pigmented cells. Experiment performed by Dr. Dennis Simpson. 
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Figure S2.2 Repair of CPD or 6-4PP in NHF1 and NHM4. Confluent cultures of NHF1 or 
NHM4 were irradiated with 12 J/m2 UVC and harvested 0, 3, 6, 12, or 24 h post irradiation 
(experiment performed in the laboratory of Dr. William Kaufmann). DNA was purified and 
CPD and 6-4PP were quantified by RIA in the laboratory of Dr. David Mitchell. 
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Figure S2.3 Relative spectral output for UVA, UVB, and UVC sources used in these 
experiments. UVC irradiation was performed with a germicidal fluorescent lamp (Sylvania 
G8T5, 90% emission at 254 nm). UVB irradiations were performed with two Philips 
TL20W/01 NB-UVB fluorescent lamps emitting between 300 and 315 nm, with a maximum 
emission at 312 nm. UVA irradiations were performed with four Houvalite F20T12BL/HO 
PUVA lamps, emitting between 300 and 400 nm, with a maximum emission at 350 nm. 
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IS ACTIVATION OF THE INTRA-S CHECKPOINT IN HUMAN FIBROBLASTS AN 
IMPORTANT FACTOR IN PROTECTION AGAINST UV-INDUCED 
MUTAGENESIS?2
 
 
 
Introduction 
The capacity to replicate and segregate the entire genome with high fidelity is a 
hallmark of normal division cycles. Furthermore, preventing replication of damaged DNA 
decreases the potential for mutations (Konze-Thomas et al., 1982). Cellular DNA constantly 
experiences damage, both as a consequence of normal cellular metabolism and respiration, 
and as a result of environmental insults. In order to cope with such genomic damage, cells 
have evolved a network of DNA damage responses (DDR) (Giglia-Mari et al., 2011), 
consisting of DNA repair mechanisms, damage tolerance pathways, and cell cycle 
checkpoints. 
Cell cycle checkpoints are systems in place to recognize damaged DNA, or aberrant 
DNA structures, and activate signaling cascades designed to halt or slow progression 
through the cell cycle, thus maximizing the time to repair such damage before DNA is 
replicated or segregated to progeny. Indeed, checkpoint failures have been shown to result 
in chromosomal abnormalities, developmental defects, and predisposition to cancer (Kastan 
and Bartek, 2004; Kerzendorfer and O'Driscoll, 2009). Upon sensing damaged DNA, cell 
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cycle checkpoints inhibit progression out of the G1 and G2 phases of the cell cycle, while the 
intra-S checkpoint slows progression through S-phase (Kastan and Bartek, 2004).  
The intra-S checkpoint can be divided into two main signaling cascades that respond 
to different forms of DNA damage. The first recognizes double strand breaks in DNA, such 
as those induced by ionizing radiation (IR). The intra-S checkpoint response to IR requires 
the proteins ATM, MRE-11, RAD50 and NBS1 and involves activation of the checkpoint 
kinases CHK1 and CHK2, promoting proteolytic degradation of CDC25A. Loss of the 
CDC25A phosphatase prevents removal of the inhibitory phosphorylation at tyr15 of CDK2, 
thus maintaining this kinase inactive, and preventing CDC45 loading and initiation at new 
replication origins (Kastan and Bartek, 2004). ATM also maintains the intra-S checkpoint 
response by signaling through the cohesion subunits Smc1 and Smc3 (Kastan and Bartek, 
2004; Kaufmann, 2009). The second main signaling cascade recognizes bulky DNA 
adducts, such as those induced by ultraviolet (UV) radiation or benzo[a]pyrene diolepoxide. 
This checkpoint response to UV was found to require the activity of checkpoint proteins 
ataxia telangiectasia and Rad3-related (ATR) kinase, and its target CHK1, to act on 
downstream substrate(s) to inhibit the firing of new origins of replication (Chastain et al., 
2006; Heffernan et al., 2002; Miao et al., 2003) and to slow down rates of DNA chain 
elongation (Petermann et al., 2006; Seiler et al., 2007; Unsal-Kacmaz et al., 2007). At sub-
lethal fluences of UV, the ATR/CHK1 pathway has been shown not to depend on 
degradation of CDC25A, but rather it has been proposed to act on the DBF4-dependent 
kinase to prevent CDC45-dependent activation of the MCM helicase, thus inhibiting new 
replicon initiation (Heffernan et al., 2007; Lee et al., 2012).  
It is well established that loss of functional ATM increases IR-induced mutation 
frequency (Xue et al., 2009) and predisposes mammals to lymphomas and other 
malignancies (Reiman et al., 2011). Although ATM is widely recognized as a tumor-
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suppressor gene, it is unclear whether this function depends primarily on the activation of 
the ATM-dependent intra-S checkpoint or on ATM’s role in other DNA damage responses. 
In contrast, loss of Atr causes embryonic lethality in mice (Brown and Baltimore, 2000; de 
Klein et al., 2000), while Seckel syndrome is a consequence of an ATR hypomorphic splice 
mutation. Seckel syndrome manifests as a developmental disease, with patients exhibiting 
dwarfism, microcephaly, and mental retardation, but cancer is not typically associated with 
the disorder (Kerzendorfer and O'Driscoll, 2009). Abrogation of the ATR/CHK1 pathway has 
clearly been shown to inhibit the intra-S checkpoint to UV (Heffernan et al., 2002; Miao et 
al., 2003), and to lead to an increase in chromosomal instability (Smith-Roe et al., 2013). 
Despite these observations, it is less clear whether abrogation of the ATR/CHK1-dependent 
S-phase checkpoint influences mutagenesis. To address this question, we employed siRNA-
mediated depletion of ATR or CHK1, or pharmacological inhibition of CHK1 kinase function, 
to inactivate the intra-S checkpoint and measured mutation frequency at the HPRT locus in 
UV-irradiated human fibroblasts. The results described here support the conclusion that in 
the presence or absence of the rapid activation of intra-S checkpoint responses, UV-
irradiated normal human fibroblasts acquire the same burden of mutations. 
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Results 
Depletion of ATR or CHK1 abrogated the intra-S phase checkpoint triggered by UV 
The activation of the intra-S checkpoint in UV-irradiated NHF1 was assessed by 
examining changes in the steady-state distribution of sizes of nascent DNA pulse-labeled 
with 3H-thymidine. Responses were compared in populations pre-treated with a non-
targeted control (NTC) siRNA and those with siRNA-mediated depletion of ATR or CHK1. 
Figure 3.1a illustrates the siRNA-mediated depletion of ATR, which in the irradiated cells 
was accompanied by a severe reduction in phosphorylation of its substrate CHK1, a known 
mediator of UV-induced S-phase checkpoint activation (Chastain et al., 2006; Heffernan et 
al., 2002; Miao et al., 2003). Velocity sedimentation analyses showed that fibroblasts pre-
treated with the NTC-siRNA (Figure 3.1b) displayed a stereotypical reduction in the 
abundance of small molecular weight (MW) nascent DNA when exposed to a low fluence of 
UVC. The selective reduction in abundance of this size class of origin-proximal, newly 
synthesized DNA represents a functional indicator of the inhibition of initiation of replication 
origins that were scheduled to fire post-irradiation (Kaufmann et al., 1980a; Kaufmann and 
Cleaver, 1981; Miao et al., 2003). Depletion of ATR (Figure 3.1c) interfered with this 
selective inhibition of the synthesis of small MW nascent DNA, thus demonstrating the 
abrogation of the intra-S checkpoint response of inhibition of replicon initiation. Similarly, 
inhibition of this S-phase checkpoint response was confirmed following siRNA-mediated 
depletion of CHK1 (Figure 3.2).  
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Figure 3.1 Depletion of ATR abrogates the intra-S checkpoint response: a) NHF1 cells 
were electroporated with NTC or ATR siRNA and UV-irradiated (sham or 2.5 J/m2) 48 h 
following electroporation. Cells were harvested and protein extracts examined by 
immunoblotting 1 h after irradiation.  b and c) Velocity sedimentation analysis of nascent 
DNA from NHF1 cells exposed to UVC (sham-closed squares or 2.5 J/m2-open diamonds) 
48 h post-electroporation with b) NTC or c) ATR siRNA; the irradiated cells were incubated 
for 30 min and then pulse labeled with 3H-thymidine for 15 min.  
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Figure 3.2 Depletion of CHK1 abrogates the intra-S checkpoint response: a) NHF1 
cells were electroporated with NTC or CHK1 siRNA. Cells were harvested 24 h later and 
protein extracts examined by immunoblotting. b and c) Velocity sedimentation analysis of 
nascent DNA from NHF1 cells exposed to UVC (sham-closed squares or 2.5 J/m2-open 
diamonds), following electroporation with b) NTC or c) CHK1 siRNA.  Cells were irradiated 
24 h post-electroporation and 30 min later were pulse labeled with 3H-thymidine for 15 min.   
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Depletion of ATR or CHK1 did not increase the UV-induced mutation frequency at the 
HPRT locus 
Mutation frequency at the HPRT locus was measured in NHF1 cells following 
depletion of ATR or CHK1 and irradiation with increasing fluences of UVC (Figure 3.3). In 
cultured fibroblasts treated with the NTC-siRNA, UV induced the formation of 6-thioguanine 
resistant mutant colonies at frequencies above the background (measured in the sham-
irradiated populations) (p<0.05 for sham vs. 7.5 J/m2, one-sided Wilcoxon rank-sum test, or 
by linear regression of all fluences). As a pre-validation of the adopted methodology, under 
the laboratory conditions used in this study, NHF1 cultures were treated with siRNA 
targeting the translesion synthesis (TLS) DNA polymerase η (Choi and Pfeifer, 2005b); an 
elevated recovery of HPRT mutant colonies was observed, as compared to the NTC siRNA-
treated population, even at fluences ≤ 4 J/m2 (see Supplemental material, Figure S3.1). In 
contrast, cells depleted of CHK1 or ATR did not display mutation frequencies higher than 
those treated with control siRNA (Figure 3.3). 
  
64 
 
Figure 3.3 Depletion of ATR or CHK1 does not increase UV-induced mutation 
frequency at the HPRT locus: a) Depletion of ATR in cells used for mutagenesis 
experiment. NHF1 cells were electroporated with NTC or ATR siRNA and irradiated (sham, 
2.5, or 5 J/m2) 48 h following electroporation. Cells were harvested and protein extracts 
examined by immunoblotting 1 h after irradiation. b) Depletion of CHK1 in cells used for 
mutagenesis experiment. NHF1 cells were electroporated with NTC or CHK1 siRNA. Cells 
were harvested 24 h later and protein extracts examined by immunoblotting. c) UV-induced 
(0, 2.5, 5, or 7.5 J/m2) HPRT mutation frequencies in NHF1 following depletion of ATR (open 
triangle) or CHK1 (closed squares) or NTC (open diamonds) expressed as mutants per 106 
surviving cells ± SEM. Values for sham or 7.5 J/m2 were slightly offset on figure to allow for 
clear illustration of error bars. In NTC-treated cells, UV induced a mutation frequency 
statistically higher than that measured in the sham-irradiated cells (p<0.05 for sham vs. 7.5 
J/m2, one-sided Wilcoxon rank-sum test, or by linear regression of all fluences). Depletion of 
ATR or CHK1 did not cause a significant difference in UV-induced mutation frequency 
(p=0.86 and 0.63, respectively, Wilcoxon rank-sum test).  
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Pharmacological inhibition of CHK1 with TCS2312 abrogated the UV-induced intra-S 
phase checkpoint 
The results described above were confirmed by experiments in which an alternative 
approach was employed to inactivate the intra-S checkpoint. Instead of depleting the cells of 
the two major kinases involved in the activation of this checkpoint, a CHK1 inhibitor 
(TCS2312) was used to block the signaling pathway while retaining normal cellular protein 
levels. First, the effect of increasing concentrations of this inhibitor on overall DNA synthesis 
rates was measured. The lowest concentrations inhibiting DNA synthesis were tested for 
their effects on the intra-S checkpoint response of inhibition of replicon initiation (see 
Supplemental material, Figures S3.2-S3.4). As was observed following depletion of ATR or 
CHK1, treatment of fibroblasts with 1 µM TCS2312 reversed the UV-induced selective 
inhibition of small MW nascent DNA observed in the control population irradiated with 1 or 
2.5 J/m2 UVC, indicating a blockage in the S-phase checkpoint signaling cascade (Figure 
3.4 and Supplemental material, Figure S3.4). 
CHK1 inhibition did not increase the UV-induced mutation frequency at the HPRT 
locus 
Mutation frequencies at the HPRT locus were measured in NHF1 cells following 
treatment with 1 µM TCS2312 and irradiation with 0, 2.5, 5, or 7.5 J/m2 UVC (Figure 3.5). 
NHF1 cells irradiated in the presence or absence of inhibitor formed 6-thioguanine resistant 
mutant colonies in a fluence-dependent manner (p<0.005, linear regression analysis). 
Despite abrogation of the S-phase checkpoint through pharmacological inhibition of CHK1, 
HPRT mutation frequencies were no different than those observed in cells not receiving the 
inhibitor. 
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Figure 3.4 CHK1 inhibitor TCS2312 abrogates the intra-S checkpoint response: 
Velocity sedimentation analysis of nascent DNA from NHF1 cells treated with the CHK1 
inhibitor TCS2312. Cells were treated with a) vehicle or b) 1 µM TCS2312 30 min prior to 
irradiation with 0 (closed squares), 1 (open circles), or 2.5 (closed diamonds) J/m2 and 
inhibitor remained until cells were harvested. Cells were pulse-labeled with 3H-thymidine 
(15 min) 30 min post-irradiation. 
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Figure 3.5 CHK1 inhibitor TCS2312 does not increase UV-induced mutation frequency 
at the HPRT locus: UV-induced (0, 2.5, 5, or 7.5 J/m2) HPRT mutation frequencies in NHF1 
following treatment with vehicle (closed diamonds) or 1 µM TCS2312 (open squares) 
expressed as mutants per 106 surviving cells (2 experiments, all points shown). In both 
vehicle and TCS2312 treated cells, UV induced a fluence-dependent increase in mutation 
frequency (p<0.005, linear regression analysis). The UV-induced mutation frequency was 
not different between cells treated with vehicle or inhibitor (p=0.97, linear regression 
analysis) 
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Colony forming efficiency and UV-induced cytotoxicity following ATR/CHK1 depletion 
or CHK1 inhibition 
In the course of performing the mutagenesis studies described above, colony 
forming assays were done in each experiment to assess the effect of siRNA-mediated 
depletion of CHK1 or ATR, or inhibition of CHK1, on overall cell survival and on UV-induced 
cytotoxicity. Depletion of either ATR (p=0.03, one-sided Wilcoxon rank-sum test) or CHK1 
(p=0.01, one-sided Wilcoxon rank-sum test) decreased colony forming efficiency in the 
absence of UV by 63% or 40%, respectively, as compared to the colony forming efficiency 
of NTC siRNA-treated cells; similarly, inhibition of CHK1 by TCS2312 reduced colony 
forming efficiency by 51% compared to the vehicle treated cells (Figure 3.6a). Loss of ATR 
or CHK1 (Figure 3.6b), or treatment with TCS2312 (Figure3.6c), also sensitized NHF1 to 
UV-induced cytotoxicity (p<0.0001 for both siRNA depletions, p<0.001 for inhibitor, by linear 
regression analysis).   
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Figure 3.6 Influence of ATR or CHK1 depletion, or CHK1 inhibition, on colony forming 
efficiency or UV-induced cytotoxicity: a) Colony forming efficiency of cells depleted of 
CHK1 (n=4) or ATR (n=6), or treated with 1 µM TCS2312 (n=2) as compared with either the 
NTC (n=10) or vehicle (n=2) treated cells. Depletion of ATR (p=0.03, one-sided Wilcoxon 
rank-sum test) or CHK1 (p=0.01, one-sided Wilcoxon rank-sum test) decreased colony 
forming efficieny from that of NTC treated cells.  b) UV-induced cytotoxicity of NHF1 after 
siRNA-mediated depletion of NTC (open diamonds), ATR (open triangles) or CHK1 (closed 
squares) as measured by colony forming efficiency (n=3-9, ± SEM). Depletion of ATR or 
CHK1 increased UV-induced cytotoxicity (p<0.0001 for both depletions, linear regression 
analysis). c) UV-induced cytotoxicity of NHF1 after treatment with vehicle (closed 
diamonds), or 1 µM TCS2312 (open squares) as measured by colony forming efficiency (2 
experiments, all points shown). The UV-induced cytotoxicity in cells treated with inhibitor 
was greater than that of vehicle treated cells (p<0.001, linear regression analysis). 
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Discussion 
Nucleotide excision repair, DNA polymerase η-dependent translesion synthesis 
(TLS), and cell cycle checkpoints are known to minimize the consequences of UV-induced 
DNA damage. Xeroderma pigmentosum (XP) is a genetic disorder characterized by 
dramatic UV sensitivity and a >1000-fold predisposition to skin cancers in areas exposed to 
solar radiation (Cleaver, 2005). XP is primarily caused by mutations in nucleotide excision 
repair genes, highlighting the importance of this pathway in protecting against UV-induced 
mutagenesis and carcinogenesis (Lehmann et al., 2011). Similarly, XP patients of the 
variant complementation group (XPV) lack functional DNA polymerase η, which is required 
for efficient synthesis across UV-induced photoproducts (Masutani et al., 1999). XPV 
patients also display increased sensitivity to sunlight, with patients typically developing skin 
cancers between the ages of 20 and 30 (Kannouche and Stary, 2003). To date it has not 
been established that aberrant cell cycle checkpoints contribute directly to UV-induced 
carcinogenesis. Although not proven to be cancer drivers, there is evidence that the G1 and 
G2 checkpoints are defective in some melanoma cell lines (Carson et al., 2012; Kaufmann 
et al., 2008; Omolo et al., 2013), but there is no evidence that the intra-S checkpoint is 
abrogated in cancers. The prevailing paradigm has been that checkpoints decrease the 
probability that damaged DNA will be replicated, allowing time for nucleotide excision repair 
to remove template lesions. The intra-S checkpoint, in particular, has been hypothesized to 
minimize mutagenesis by inhibiting the replication of damaged DNA (Kaufmann, 2009), or 
by improving the efficiency of TLS across DNA photoproducts by facilitating PCNA 
ubiquitination (Bi et al., 2005; Kaufmann, 2009; Yang and Zou, 2009) and recruitment of 
DNA polymerase η (Gohler et al., 2011; Speroni et al., 2012). 
Absent or malfunctioning components of the IR-induced DDR that regulate cell cycle 
checkpoint pathways lead to a number of human disorders, including ataxia telangiectasia 
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(AT), AT-like disorder, Nijmegen breakage syndrome, and Li Fraumeni syndrome. Mutations 
in ATM, NBS1, MRE11 and CHK2 have been linked to increased cancer susceptibility, and 
ATM-deficient cells have been shown to be hypermutable in response to IR (Xue et al., 
2009). The proteins coded by these genes are involved in multiple facets of the IR-induced 
DDR, including double strand break repair and multiple cell cycle checkpoints (Kastan and 
Bartek, 2004); hence, it is not clear if loss of the intra-S checkpoint contributes to the 
increase in susceptibility to malignancy. Mutations identified as causing Seckel syndrome, 
either in ATR, ATRIP, or PCNT, result in impaired UV-induced DDR (Alderton et al., 2004; 
Griffith et al., 2008; Ogi et al., 2012), but elevated cancer risk is not typically associated with 
this disease. It is unclear whether a malfunctioning ATR/CHK1-dependent intra-S 
checkpoint results in increased mutation frequencies in cells exposed to agents that induce 
bulky DNA lesions (e.g. UV or benzo[a]pyrene diolepoxide). Results shown here confirmed 
that upon depletion of ATR or CHK1 the intra-S checkpoint was not activated by UV. 
Similarly, pharmacologic inhibition of the CHK1 kinase abrogated the UV-induced inhibition 
of replicon initiation. However, the UV-induced mutation frequency at the HPRT locus was 
not increased relative to matched controls. These results suggest that loss of ATR/CHK1 
signaling, at least during the first S phase following UV exposure when cells must cope with 
the highest density of DNA photoproducts, does not result in higher mutation frequencies, 
even at a locus (HPRT) where point mutations, as well as small or large deletions, result in 
the same phenotype (6-thioguanine resistance). 
To date, little information is available regarding the role of the ATR/CHK1 pathway as 
a tumor suppressor. However, some insight can be derived from research describing 
germline or somatic mutations that are presumed to affect this pathway, or by examining 
data from animal models targeting ATR/CHK1. A germline mutation in the FAT domain of 
ATR in an autosomal-dominant oropharyngeal cancer syndrome (Tanaka et al., 2012), or a 
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mutation in the checkpoint mediator CLSPN in the germline of a familial breast cancer case 
(Zhang et al., 2009), did not impair intra-S checkpoint activation as measured by CHK1 
phosphorylation. Somatic mutations in ATR and CHK1 have also been reported in 
endometrial, colorectal, and stomach cancers, particularly in mismatch repair deficient cells 
with microsatellite instability (MSI) (Lewis et al., 2007; Menoyo et al., 2001; Vassileva et al., 
2002). It is unclear whether or not these mutations compromise the activation of the intra-S 
checkpoint, and whether they are cancer drivers or passenger mutations. One MSI+ colon 
cancer cell line, heterozygous for an ATR truncation mutation, was shown to be impaired in 
the UV-induced phosphorylation of CHK1 and the late-S/G2 arrest induced by topotecan 
(Lewis et al., 2005). In this same study, chronic myelogenous leukemia cells transiently 
transfected with an ATR truncation mutant allele displayed a similar phenotype while 
retaining expression of endogenous ATR, suggesting that the truncation mutation acts in a 
dominant negative manner. We cannot rule out the possibility that a dominant negative ATR 
or CHK1 could influence UV-induced mutation frequency. However, such a mechanism 
would most likely not depend on the inhibition of CHK1 kinase activity, as we did not 
observe a change in UV-induced mutation frequency upon pharmacological inhibition of 
CHK1 kinase. 
Animal models for ATR or CHK1 heterozygosity have also shown enhanced 
tumorigenesis (Brown and Baltimore, 2000; Fang et al., 2004; Gilad et al., 2010; Liu et al., 
2000; Tho et al., 2012) or tumor progression (Tho et al., 2012). The reported effects, 
however, often require synergistic combination with a cancer-driver mutation. For example, 
loss of one allele of Chk1 or p53 in mouse mammary tissue did not result in tumor formation, 
but when combined, the loss of one allele at each locus resulted in 60% tumor formation 
(Fishler et al., 2010). Similarly, Atr+/- ,Mlh-/- mice developed cancer at much higher rates 
(71%) than their Atr+/- (0%) or Mlh-/- (17%) littermates (Fang et al., 2004). It is known that 
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Atr and Chk1 knockout mice are not viable (Brown and Baltimore, 2000; de Klein et al., 
2000; Liu et al., 2000) and that loss of either protein enhances cytotoxicity; therefore, the 
tumorigenic effects described above might depend on a threshold of expression of these 
proteins. The implications to our findings would be that below this threshold, cell survival is 
compromised to the point that enhanced mutagenesis may not be observed in our in vitro 
system. It has yet to be determined if moderately depleted levels of ATR or CHK1, such as 
those observed in heterozygous knockout animals, would allow cell survival at the cost of 
genomic instability and increased mutagenesis. 
There is evidence that intra-S checkpoint signaling affects TLS (Bi et al., 2005; 
Gohler et al., 2011; Speroni et al., 2012; Yang et al., 2008), and it is conceivable that intra-S 
checkpoint inhibition is also inhibiting efficient TLS. Because mutagenesis requires 
replication of the damaged DNA, error-prone TLS is considered a prominent driver of UV-
induced mutagenesis. Thus, even if intra-S checkpoint inhibition was allowing newly fired 
replication forks to encounter UV-induced DNA damage sites, TLS would be required to 
replicate across the photolesions, and to potentially induce mutations. If ATR or CHK1 were 
important for efficient bypass synthesis (in addition to their known checkpoint functions), it 
stands to reason that the depletion of these enzymes might inhibit TLS and reduce mutation 
frequency. It has been suggested that ATR, CHK1, and other components of the replication 
fork protection complex, not only operate cooperatively to activate the intra-S checkpoint, 
but that they possess separate functions for preservation of intrinsic chromosomal stability 
(Smith-Roe et al., 2013); also that loss of ATR or CHK1 increases genomic instability at 
common fragile sites (Casper et al., 2002; Durkin et al., 2006). Common fragile sites tend to 
be replicated late in S phase; the formation of secondary structures within the fragile sites is 
thought to slow progression of replication forks (Durkin et al., 2006; Durkin and Glover, 
2007). It is of note that the active HPRT gene is replicated early in S-phase (Schmidt and 
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Migeon, 1990). Perhaps the primary function of the intra-S checkpoint proteins is to 
preserve genomic stability at difficult to replicate regions and/or regions replicated late in S-
phase, and that inhibition of replicon initiation in response to UV is not of primary importance 
in minimizing UV-induced mutations in regions of the genome that are replicated more easily 
or early in S-phase. 
The results reported here show that severe depletion of ATR/CHK1 did not increase 
UV-induced mutagenesis, perhaps as a consequence of preferential cytotoxicity in cells 
most depleted of CHK1 or ATR, or decreased TLS efficiency. There has been increasing 
interest in developing ATR or CHK1 kinase inhibitors as therapeutics designed to sensitize 
cancer cells to the cytotoxic effects of clinical drugs (Chen et al., 2012). Our results agree 
with many others showing that CHK1 inhibition sensitizes cells to DNA damaging agents, 
including cisplatin in non-small cell lung carcinoma cells (Mack et al., 2003) and 
camptothecin in colon cancer cells (Furuta et al., 2006). An attractive idea has been that 
some cancer cells are selectively sensitive to ATR/CHK1 inhibition in combination with DNA 
damaging agents, perhaps because of loss of the p53-dependent G1 checkpoint (Toledo et 
al., 2011). Although our results indicate that loss of ATR/CHK1 or inhibition of CHK1 does 
not increase UV-induced mutagenesis, it remains to be determined if this would hold true for 
other DNA-damaging chemotherapeutics. If so, our results would suggest that the 
combination of ATR/CHK1 inhibitors and chemotherapy would have the additional 
advantage of not enhancing the probability of drug resistant clones or secondary, 
chemotherapy-induced cancers emerging from an increase in mutagenesis. 
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Materials and methods 
Cell culture and UV treatment 
The normal human fibroblast cell line NHF1-hTERT was derived from neonatal 
foreskin fibroblasts (Boyer et al., 1991) and immortalized by ectopic expression of the 
catalytic subunit of human telomerase (Heffernan et al., 2002). Cells were cultured in 
minimum essential medium (GIBCO) supplemented with 10% fetal calf serum and 2 mM L-
glutamine, and were maintained in humidified 95% air and 5% CO2 at 37°C. For UV 
irradiations, cells were rinsed in phosphate buffered saline, all extra liquid removed, and the 
culture plates irradiated without the lids. Irradiation was performed with a fluorescent 
germicidal lamp emitting primarily 254 nm UVC (Sylvania G8T5, 90% emission at 254 nm). 
Control plates were treated under identical conditions, but were not exposed to UV (sham 
controls). Lamp irradiance was measured using a UVX Digital Radiometer (Ultra-Violet 
Products Inc.) using the UVX-25 sensor (250-290 nm range, calibrated at 254 nm). 
Protein depletion 
siRNA was introduced by electroporation (100 pmol siRNA per 106 cells), using the 
normal human dermal fibroblast kit VDP-1001 (Lonza) and program U-23 on a Nucleofector 
2b electroporation device (Lonza). ON-TARGET plus duplex siRNAs were purchased from 
Dharmacon: NTC (D-001210-2), CHK1 (J-003255), and ATR SMART pool (L-003202). 
Experiments were conducted 24 h post electroporation with CHK1 or 48 h post-
electroporation with ATR. 
CHK1 inhibitor TCS2312 
The CHK1 inhibitor TCS2312 (Tocris) was dissolved in sterile water (1 mM stock 
solution) and added to cell culture medium at the indicated concentrations. For velocity 
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sedimentation experiments, inhibitor was added 30 min prior to irradiation and kept in the 
medium during the subsequent 30 min incubation and the 15 min 3H-thymidine pulse-
labeling period. For mutagenesis and cytotoxicity experiments, inhibitor was added 30 min 
prior to irradiation and removed six hours after the UV exposure, at which time the cells 
were rinsed with buffered saline and fed with fresh culture medium. 
Western blotting and antibodies 
One hour after irradiation, cells were harvested by trypsinization, pelleted and flash 
frozen in liquid nitrogen. Frozen pellets were resuspended in lysis buffer (8 M urea, 5 M 
NaH2PO4, 1 M Tris-HCl pH 8) on ice for 30 min and then clarified by centrifugation (16000 x 
g and 4°C). The Bio-Rad Protein Assay kit was used to determine protein concentration. 
Equal volumes of loading buffer (125 mM Tris pH 6.8, 20% glycerol, 10% β-
mercaptoethanol, 4% sodium dodecyl sulfate, 0.05% bromo-phenol blue) were combined 
with protein lysates and samples were boiled for 5 min. Equal amounts of protein were 
loaded onto BioRad Criterion-TGX 4-15% gradient gels (approximately 150-200 V, 2-4 h). 
Size-separated proteins were transferred overnight (100 mA) onto a nitrocellulose 
membrane. After blocking in 5% powdered milk in TBST (0.5% Tween-20, 10 mM Tris-HCl, 
10 mM NaCl, pH=7.4), primary antibodies were applied. The following antibodies were used: 
rabbit anti-P-CHK1 S345 (Cell Signaling), mouse anti-CHK1, goat anti-ATR, and goat anti-
Actin (Santa Cruz). Following application of HRP-conjugated secondary antibody 
(Amersham), bands were visualized on film by enhanced chemiluminescence (ECL). An 
Alpha Innotech Fluor-Chem HD2 was used to measure the densitometry of film bands. 
Velocity sedimentation 
As previously described (Day et al., 2011; Kaufmann et al., 1980b), the steady-state 
size distribution of nascent DNA was determined by centrifugation in an alkaline sucrose 
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density-gradient 45 min after UV irradiation. Cells were uniformly pre-labeled during 
logarithmic growth by incubation with 14C-thymidine (5-10 nCi/mL) for at least 36 h. Medium 
containing 14C-thymidine was removed overnight and cells treated the following day. Thirty 
minutes after UV-irradiation, cells were incubated with 25 µCi/mL 3H-thymidine for 15 min. 
Cells were rinsed in PBS then scraped on ice into 0.1 M NaCl, 0.01 M EDTA (pH 8) and 
then passed through a 22G needle 5x. An equal volume of lysis buffer (1 M NaOH, 0.02 M 
EDTA) was added to 0.5 mL of lysed cells and the mixture added on top of an alkaline 
sucrose gradient (5-20% sucrose in 0.4 M NaOH, 2 M NaCl, 0.01 M EDTA). These gradients 
were left under fluorescent lighting for 45 min and then centrifuged in a Beckman SW32Ti 
rotor for 5 h at 25000 rpm and 20°C. Gradients were fractioned through a hole punched in 
the bottom of the centrifuge tube and acid-precipitable material filtered onto a glass 
microfiber filter (Whatman GF/C 24mm). The glass microfiber filters were then analyzed by 
liquid scintillation counting. All experiments included cells pre-labeled with 14C-thymidine but 
not pulse-labeled with 3H-thymidine. These samples were used to measure the 14C CPM 
values detected in the 3H channel during liquid scintillation counting. Normalized 3H CPM 
were the 3H CPM in each fraction, corrected for the 14C spillover, and normalized to the total 
14C in the gradient, which is proportional to the number of cells. 
HAT selection 
Pre-selection for functional HPRT in cells used for mutagenesis experiments was 
performed by expanding cultures in medium supplemented with 1 x HAT (100x lyophilized 
HAT contains 10 mM sodium hypoxanthine, 40 M aminopterin, and 1.6 mM thymidine) for 
10-14 days (Bassett et al., 2004). New aliquots of frozen and stored HAT selected cells 
were used for every HPRT mutagenesis experiment. Cell cultures were expanded in normal 
medium without HAT for 10-14 days prior to mutagenesis experiments.  
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Mutagenesis 
Mutagenesis experiments were performed by plating electroporated cells at 1x106 
per dish or 5x105 for cells to be treated with vehicle/inhibitor (2 plates per condition). Cells 
were irradiated 24 h (CHK1 or inhibitor experiments) or 48 h post-electroporation (ATR). 
After irradiation, cells were maintained in logarithmic growth for 4-6 population doublings. 
HPRT mutants were selected by plating 4x104 cells per 10-cm dish (55 dishes per 
treatment) in medium containing 40 µM 6-thioguanine. At the time of selection, colony 
forming efficiency was determined by plating 400 cells per dish in medium lacking 6-
thioguanine. Approximately two weeks post-seeding, all selective and colony forming 
efficiency plates were fixed in 3:1 methanol:acetic acid and stained with 0.05% crystal violet, 
and colonies with more than 50 cells were counted. Mutation frequencies were calculated 
from the number of plates without any mutant colonies, using the Poisson distribution as 
follows: [-ln (number of plates without 6-thioguanine resistant colonies/total number of 
plates)]/[(number of cells plated for selection) x (colony-forming efficiency at time of 
selection)]. 
Cytotoxicity experiments 
Concurrent with the mutagenesis experiments, cytotoxicity was determined by colony 
forming assay at the time of treatment. Cells depleted of CHK1 (and their matched NTC 
controls) were plated at a density of 1000 cells per 10-cm dish and irradiated 24 h after 
electroporation. Cells depleted of ATR (and their matched NTC controls) were left in culture 
for 24 h post-electroporation and re-seeded at a density of 500 cells per 10-cm dish, and 
irradiated 48 h after electroporation. Cells treated with 1 µM TCS2312 or vehicle were 
seeded at a density of 500 cells per 10-cm dish and irradiated 30 min after the addition of 
inhibitor. The inhibitor remained on the cultures for 6 h post-irradiation. These cell densities 
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resulted in approximately 100 colonies per dish for the vehicle or NTC-treated, sham-
irradiated plates, and 3-6 plates per condition were counted. Plates were fed weekly and 
colonies fixed in 3:1 methanol:acetic acid and stained with 0.05% crystal violet 
approximately two weeks later. Colonies with more than 50 cells were counted. 
Statistical methods 
Statistical comparisons were performed in order to determine whether UVC induced 
mutation frequencies, UV-induced cytotoxicity, or colony forming efficiency following siRNA-
mediated depletion of ATR or CHK1, or pharmacological inhibition of CHK1, varied 
significantly from the NTC or vehicle controls. The linear regression model was used to carry 
out data analysis for estimating various parameters of interest with appropriate 95% 
confidence intervals, and hypothesis testing. Specifically, the linear model was used to 
model the mutation frequency and cell survival percentage as response variables, using 
UVC fluence level and siRNA-mediated protein depletion or inhibitor treatment as 
covariates. The interaction effect between covariates was also considered to make the 
model more flexible. Wald statistics were used to determine the statistical significance of the 
comparisons. The Wilcoxon rank sum test was used to do group-wise comparisons at 
different UVC fluences and with different protein depletions to test for statistical differences 
in mutation frequency or colony forming efficiency. Exact test statistics were used to 
determine the statistical significance of the comparisons. All statistical analyses were 
performed using SAS 9.3 (SAS Institute Inc., Cary, NC). 
. 
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Supplemental material 
 
Figure S3.1 Depletion of DNA polymerase η increases UV-induced mutagenesis. 
siRNA mediated depletion of DNA polymerase η (Dharmacon ON-TARGET J-006454-09, 
closed circles) increased UV-induced (2, or 4 J/m2) mutation frequency at the HPRT locus 
compared to cells treated with NTC siRNA (open diamonds). Cells were irradiated 24 h post-
electroporation, n=1. 
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Figure S3.2 Inhibition of DNA synthesis by TCS2312. NHF1 were uniformly pre-labeled 
in medium containing 5 nCi/mL 14C-thymidine for ~48 h prior to replating in 6-well plates. 
Indicated concentrations of TCS2312 were added to the medium for 1 h prior to pulse 
labeling for 15 min with 10 µCi/mL 3H-thymidine. Cells were then rinsed twice in ice cold 
phosphate buffered saline and fixed in cold 5% trichloroacetic acid for 30 min. After fixing, 
wells were rinsed twice with 5% trichloroacetic acid and twice with 95% ethanol. Cells were 
then dissolved in 0.3 N sodium hydroxide and analyzed by liquid scintillation counting. 
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Figure S3.3 Inhibition of CHK1 kinase activity enhances CHK1 phosphorylation. NHF1 
were treated with 0, 1, or 2 µM TCS2312 for 30, 60, or 90 min and P-CHK1 (S345) analyzed 
by immunoblotting. P-CHK1 levels in UV-irradiated NHF1 (45 min post-irradiation) included 
for comparison. 
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Figure S3.4 Velocity sedimentation analysis of nascent DNA from NHF1 cells treated 
with the CHK1 inhibitor TCS2312. Cells were treated with a) 0, b) 1, or c) 2 µM TCS2312 
30 min prior to irradiation with 0 (closed squares) or 1 J/m2 (open circles) and inhibitor 
remained until cells were harvested. Cells were pulse-labeled with 3H-thymidine (15 min) 30 
min post-irradiation. 
  
 CHAPTER 4 
CONCLUSIONS AND FUTURE DIRECTIONS 
Much research has been devoted to examining the mechanisms of skin cancers and 
UV-induced carcinogenesis. Many risk factors for developing skin cancers have been 
proposed, including tobacco use, immunosuppression, HPV infections, chemical exposures 
(dioxins, PAH, coal tars, pesticides, arsenic), and certain genetic disorders (XP, Bloom 
syndrome, Fanconi anemia). However, it has become widely accepted that exposure to 
solar UVR is the primary etiological cause of both NMSC and melanomas. The primary 
mechanism of UVR-induced skin carcinogenesis is thought to involve its ability to act as a 
direct mutagen. It has been clearly demonstrated that UVR is genotoxic and multiple forms 
of UVR-induced DNA damage have been identified.  Despite the fact that UVR has been 
extensively studied and that much is known about UV-induced skin cancers, there remain 
many unanswered questions. What are the contributions of different wavelengths to UV-
induced skin carcinogenesis? What role does skin inflammation (erythema) play? Which 
particular UV-induced DNA lesion(s) is/are responsible for mutagenesis? Are there other 
genetic or environmental factors that influence susceptibility to UV-induced skin cancers? 
Are tanning bed exposures safe? These have been difficult questions to answer due to the 
highly complex nature of UV-induced skin cancers. UVR includes a broad spectrum of 
wavelengths that penetrate skin differently, cause multiple and different forms of DNA 
damage as well as other forms of cellular damage, and induce potentially varying biological 
responses. These characteristics make studying UVR not unlike elucidating the 
carcinogenic effect of chemical mixtures. It has been a challenge to elucidate the 
importance of the contributions from different components of UVR to skin carcinogenesis. In 
an attempt to answer some of these questions, investigators have looked to model systems 
to break down complex biological responses to UVR into individual components and attempt 
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to examine the relative contribution of these components to the final outcomes. While 
models have become increasingly specific in order to address isolated systems, it is also 
important to recognize the aggregate effect of combining these individual components to 
recapitulate real world UVR exposures and biological responses.  
Early studies examining the wavelength dependence of UVR-induced cytotoxicity 
and mutagenicity indicated that perhaps there was a relationship between these biological 
outcomes and wavelength. Enninga et al reported that cytotoxicity and mutation frequency 
at the HPRT locus increased in normal human fibroblasts as wavelength increased, when 
compared on the basis of equal T4 endonuclease sensitive sites (Enninga et al., 1986). The 
authors concluded that either 1) repair systems are inhibited by longer wavelengths, 2) a 
different spectrum of pyrimidine dimers was induced by longer wavelengths, or 3) other 
types of lethal and mutagenic lesions are produced by longer wavelengths of UVR. While 
some of these explanations are supported by experimental evidence, other studies have not 
confirmed the main findings. Subsequent experiments producing survival curves with 
different wavelength lamps indicated that human fibroblasts were more sensitive to UVC 
than they were to a narrow band UVB lamp, when compared on the basis of CPD density 
measured by immunostaining of exposed cells (Clingen et al., 1995). Mutagenesis studies 
have also yielded divergent results. Mutation frequencies in a shuttle vector containing the 
lacZ gene were examined in UVA- or UVB-irradiated 293 transformed human embryonic 
kidney cells (Robert et al., 1996a). These authors did not employ dosimetry, but instead 
relied upon cytotoxicity to normalize results and allow comparisons of mutation frequency 
between the two sources of UVR. Their results showed that at 10% cell survival, mutation 
frequencies were equal for UVA- or UVB-irradiated cells. Only when irradiated with fluences 
resulting in less than 10% cell survival, fluences that many would consider biologically 
irrelevant, did they observe a modestly higher mutation frequency in UVA-irradiated cells.  
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Other research concluded that the mutation frequency at the HPRT locus of UVA irradiated 
NHF was 3.5 times higher than an “equitoxic” fluence of UVB, although cell survival values 
for these fluences were not reported and dosimetry was not performed (Kappes et al., 
2006).  
The results reported here suggest that we did find a slight increase in cytotoxicity for 
NHF1 irradiated with UVA as compared to those irradiated with UVB or UVC inducing equal 
CPD densities. We could speculate that UVA is inducing additional damage to DNA above 
the measured CPD densities (see below) or other cellular compartments, for instance ROS-
mediated oxidative damage to cellular proteins and lipids. Although UVA displayed 
enhanced cytotoxicity (over that of UVB or UVC) when analyzed by linear regression 
analysis, there was no statistically significant decrease in the D0 value for UVA-irradiated 
cells, suggesting that any such difference was minimal. In addition, we did not find a 
difference in the UV-induced mutation frequency between cells irradiated with UVA or UVB 
at fluences inducing equal CPD densities. It should be noted that our UVA lamps emitted 
approximately 5.7% of their radiant output in the UVB range and it is possible that this UVB 
component significantly contributed to the biological effect measured here, including a 
substantial proportion of the measured CPD and 6-4PP. Thus, it is also possible that a pure 
UVA source could less efficiently produce CPD and more efficiently induce oxidative 
damage to DNA, thereby altering the mutation frequency per CPD and the mutational 
spectrum as well. Although perhaps not ideal for such mechanistic studies, the proportion of 
UVB in our UVA source is not unlike that found in terrestrial sunlight. Even in studies where 
differences in mutation frequencies were noted, mutation spectrum analysis still provides 
little support for the role of UV-induced oxidative DNA damage in mutagenesis (Ikehata et 
al., 2008; Kappes and Runger, 2005; Kappes et al., 2006).  
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Similarly, we found no evidence that UVA-induced oxidative DNA damage was 
contributing to activation of the intra-S checkpoint. When normalized on the basis of CPD 
density, both UVC and UVA irradiated NHF1 displayed nearly identical activation of intra-S 
checkpoint signaling (phosphorylation of CHK1), inhibition of replicon initiation (after low 
dose UVR), and inhibition of DNA strand growth (after higher fluences of UVR). Dose-
response curves for the generation of 6-4PP indicate that these lesions are produced in less 
abundance than are CPD, and that shorter wavelengths of UVR more efficiently produce 6-
4PP than longer wavelengths, even when normalized on the basis of CPD density. It has 
been suggested that a 6-4PP represents a stronger block to the replication machinery than 
does a CPD, perhaps as a consequence of a more complex TLS bypass mechanism (Gibbs 
et al., 2005; Li et al., 2002). UVC induced 2 and 1.3 times as many 6-4PP per CPD than did 
UVA or UVB, with no difference in intra-S checkpoint function. Thus, it seems unlikely that 6-
4PP contribute more to intra-S checkpoint activation than do the much more abundant CPD, 
since if this were the case it would be expected that all measures of intra-S checkpoint 
function would have been higher in cells irradiated with UVC. We cannot rule out that 
different experimental systems or other cell types (with variable antioxidant capabilities) 
might have generated measurable UVA-induced oxidative damage and that such damage 
could influence DNA synthesis. However, we did not detect 8-oxo-dG in UVA-irradiated 
NHF1 and must conclude that ROS were not produced in levels high enough to affect DNA 
synthesis under our experimental conditions.  
In an attempt to break down the complexity of in vivo responses to solar radiation, 
the studies employed here have utilized cellular models to examine specific biological 
responses to UVR. While valuable tools for breaking down complex issues into mechanistic 
research questions, these simplifications can come at the cost of potentially overlooking 
important considerations. For instance, the research models employed here examined 
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dermal fibroblasts growing in a monolayer. This is neither the target cell of solar radiation-
induced carcinogenesis nor do they model the structure and cellular interactions of real skin. 
These could be important considerations when accounting for both “dose”, e.g. incident 
radiance and the penetration of different wavelengths of UVR, the antioxidant potential of 
different cell types, or the role(s) of melanin in protecting and/or sensitizing skin cells to 
carcinogenesis; or when examining the “response”, e.g., potential differences in DNA 
damage repair capacity, or differences in the magnitude of other biological endpoints being 
measured. Thus, future studies may consider utilizing cell types and systems that better 
model in vivo exposures. Indeed, advances in melanocyte and keratinocyte culturing are 
continuously allowing researchers to more easily use these target cells in experiments (see 
Figures S2.1 and S2.2). Similarly, researchers are creating model systems that better mimic 
natural skin and using these systems to address important biological questions (Ikuta et al., 
2006; Li et al., 2011). 
The work presented in Chapter 3 questioned the long-standing dogma that the ATR-
dependent intra-S checkpoint serves as a protective measure to minimize mutations 
induced by agents that cause helix-distorting DNA lesions, such as UVR. Initially, it seemed 
that this would be an easy hypothesis to support experimentally; it seemed obvious that 
inhibiting the intra-S checkpoint response would increase UV-induced mutagenesis. What 
were projected to be preliminary experiments en route to investigating other scientific 
questions turned out to be much more complex. Contrary to expectations, intra-S checkpoint 
inhibition did not increase UV-induced mutation frequency at the HPRT locus, either by 
depletion of ATR or CHK1, or by pharmacological inhibition of CHK1 kinase function. It is 
clear that these proteins are important to the intra-S checkpoint response, and that this 
response can be inhibited by depletion of the proteins or by inhibiting their signaling 
cascade. Given that ATR and CHK1 are essential proteins, it is also clear that they perform 
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vital cellular functions.  Our results lead to the conclusions that either 1) the intra-S 
checkpoint does protect against UV-induced mutagenesis and that our model system was 
not suited to elucidating this role or 2) the intra-S checkpoint does not protect against UV-
induced mutagenesis and that the vital role of these essential proteins is independent of the 
intra-S checkpoint response to UVR.  
There are several possible explanations for the lack of increased mutation frequency 
observed in NHF1 after inhibition of the intra-S checkpoint. One possibility is that abrogation 
of the intra-S checkpoint may reduce the efficiency of TLS. There is some evidence that 
proteins vital to intra-S checkpoint responses might also influence TLS.  H2199 human lung 
carcinoma cells depleted of ATR, or expressing a kinase-dead CHK1 showed lower BPDE-
induced PCNA ubiquitination and lower association between PCNA and Polκ (Bi et al., 
2005). ATR was also shown to phosphorylate chromatin-bound Pol η in response to UVR, 
perhaps facilitating Pol η loading onto PCNA (Gohler et al., 2011). Finally, CHK1 has been 
implicated in damage-induced PCNA ubiquitination (Bi et al., 2005; Yang et al., 2008; Yang 
and Zou, 2009); and CHK1-PCNA interactions and subsequent release of CHK1 from 
chromatin were shown to be important in Pol η-mediated replication of damaged DNA 
(Speroni et al., 2012). These data suggest that intra-S checkpoint proteins are important for 
efficient TLS across damaged template DNA. Because mutagenesis requires replication of 
the damaged template, error-prone TLS is considered a prominent driver of UV-induced 
mutagenesis. Thus, even if intra-S checkpoint inhibition was allowing newly fired replication 
forks to encounter UV-induced DNA damage sites, TLS would be required to replicate 
across the photolesions, and to potentially induce mutations. If ATR or CHK1 were important 
for efficient bypass synthesis (in addition to their known checkpoint functions), it stands to 
reason that the depletion of these enzymes might inhibit TLS and reduce mutation 
frequency, even if abrogation of the intra-S checkpoint function were allowing a greater 
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number of replication forks to encounter DNA damage sites. That pharmacological inhibition 
of CHK1 kinase function did not affect mutation frequency is more difficult to explain with 
this model, since it is not clear whether CHK1 kinase activity is required for efficient TLS. It 
has been reported that expression of kinase dead CHK1 inhibited BPDE-induced PCNA 
ubiquitination in H1299 cells (Bi et al., 2005) or that it did not inhibit UV or HU-induced 
PCNA ubiquitination in HeLa cells (despite that depletion of CHK1 did) (Yang et al., 2008); 
thus, it is less clear if inhibition of CHK1 kinase activity would both abrogate the intra-S 
checkpoint response and inhibit efficient TLS. 
It has also been suggested that RFPC proteins function not only to cooperatively 
activate the intra-S checkpoint, but that they possess separate functions for preservation of 
intrinsic chromosomal stability (Smith-Roe et al., 2013), and that loss of ATR or CHK1 
increases genomic instability at common fragile sites (Casper et al., 2002; Durkin et al., 
2006). Common fragile sites tend to be replicated late in S phase, possibly due to a lack of 
proximal replication origins and due to the formation of secondary structure within the fragile 
site, thought to slow progression of replication forks (Durkin et al., 2006; Durkin and Glover, 
2007). One possibility is that the primary function of the RFPC proteins is to preserve 
genomic stability at such difficult to replicate regions, and that inhibition of replicon initiation 
in response to UVR is not of primary importance in minimizing UV-induced mutations in 
regions of the genome that are replicated more easily. Cells depleted of ATR do accumulate 
chromosomal breaks despite apparently normal progression through the S phase (Smith-
Roe et al., 2013), supporting the role of ATR in preserving genomic stability in late-
replicating and difficult to replicate regions of the genome. Indeed, differences in mutation 
frequency following intra-S checkpoint inhibition might be observed in regions of the genome 
containing fragile sites. Another possibility is that the intra-S checkpoint serves to protect 
late replicating genes and that because the active HPRT gene is replicated early in S-phase 
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(Schmidt and Migeon, 1990), activation of the checkpoint does not inhibit the firing of HPRT-
replicating origins. Examining the UV-induced mutation frequency, following checkpoint 
inhibition, in a locus that is replicated late in S phase might yield different results than 
observed in our experiments. These two possibilities may be interdependent; 
temporal/spatial regulation of DNA replication and the proteins involved in the intra-S 
checkpoint may serve to protect regions of the genome that are inherently more difficult to 
replicate; such heterochromatic regions and regions with a high degree of secondary 
structure are typically replicated late in S phase (reviewed in (Herrick, 2011)).  
Perturbations to other DNA damage responses, including DNA repair systems and 
cell cycle checkpoints, have been identified in human cancers, and there is strong evidence 
that such alterations contribute to a mutator phenotype in cancers and pre-cancers (Carson 
et al., 2012; Kerzendorfer and O'Driscoll, 2009; Omolo et al., 2013). To date, there is little 
evidence that a misfunctioning intra-S checkpoint contributes directly to carcinogenesis. 
Seckel syndrome patients, germline mutations in RFPC genes, somatic RFPC gene 
mutations found in cancers, and heterozygous ATR or CHK1 mouse models, all provide 
starting points for further examining the role of the ATR-dependent intra-S checkpoint in 
protecting against carcinogenesis. Further mechanistic investigation is needed to determine 
if these alterations are abrogating intra-S checkpoint response, and if they contribute to 
mutagenicity and/or carcinogenicity. 
Interestingly, although cells derived from Seckel patients have been shown to be 
sensitive to UV (O'Driscoll et al., 2003), display chromosomal instability at common fragile 
sites (Casper et al., 2004), and to have reduced HU-induced CHK1 phosphorlyation 
(O'Driscoll et al., 2007), there is no published information examining intra-S checkpoint 
function in Seckel patients. Velocity sedimentation experiments or DNA fiber spreading 
experiments with Seckel-derived cells could determine if mutations associated with Seckel 
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syndrome affect intra-S checkpoint function. Furthermore, it has not been established that 
cells derived from Seckel patients are hypermutable.  
Germline mutations in ATR (Tanaka et al., 2012) or CLSPN (Zhang et al., 2009) 
have been identified in human cancers, but it is unclear whether these mutations affect intra-
S checkpoint function. Although no functional assessments of checkpoint function were 
reported, neither of these studies observed decreased CHK1 phosphorylation in response to 
hydroxyurea (ATR) or to UV (CLSPN). Again, it is unclear if these germline mutations affect 
mutagenesis. The authors reported that the A6431G mutation in the FAT domain of ATR 
reduced basal p53 levels and also reduced HU-induced increases in p53 levels, leading 
them to speculate that this germline mutation was promoting tumorigenesis by reducing p53 
signaling via disruption of ATR-AIMP3 (aminoacyl tRNA synthetase interacting 
multifunctional protein 3) interactions (Tanaka et al., 2012).  
Somatic ATR and CHK1 mutations have also been described in endometrial, 
colorectal, and stomach cancers, particularly in mismatch repair deficient cells with 
microsatellite instability (Lewis et al., 2005; Lewis et al., 2007; Menoyo et al., 2001; 
Vassileva et al., 2002), and may have defective intra-S checkpoint signaling and impaired S-
phase arrest in response to topotecan (Lewis et al., 2005). It would be interesting to 
determine if the dominant negative mutation in ATR (truncation mutation in codon 776 or 
778 of exon 10) prevents UV-induced inhibition of replicon initiation or DNA strand growth, 
or produces an elevated UV-induced mutation frequency.  
Finally, mouse models for Atr or Chk1 deficiency have been utilized (homozygous 
deletion of either gene is embryonic lethal) to examine the effect of heterozygous deletion of 
either gene on carcinogenesis (Brown and Baltimore, 2000; Fang et al., 2004; Fishler et al., 
2010; Gilad et al., 2010; Liu et al., 2000; Tho et al., 2012). There is indication that loss of 
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one Atr allele reduces UV-induced survival and aphidicolin-induced Chk1 phosphorylation 
(Fang et al., 2004), suggesting that loss of one allele  is sufficient to inhibit intra-S 
checkpoint signaling. However, no functional assessment of Atr-dependent DNA damage-
induced inhibition of replicon initiation has been performed in cells derived from Atr+/- mice. It 
is also not clear if the increased tumor incidence observed in some Atr+/- or Chk+/- mouse 
models is due to elevated mutation frequencies in the cells with the heterozygous deletions, 
relative to the +/+ genotypes at these loci. 
It is noteworthy that Seckel patients do not display elevated cancer risks 
(Kerzendorfer and O'Driscoll, 2009), and that it has been difficult to identify somatic or 
germline mutations that both abrogate intra-S checkpoint function and clearly contribute to 
carcinogenesis. ATR and CHK1 are both essential proteins (Brown and Baltimore, 2000; Liu 
et al., 2000), and depletion of many RFPC proteins drastically reduces cell survival (Smith-
Roe et al., 2013), indicating that these proteins have essential functions. These essential 
functions may very well be separate from the intra-S checkpoint response, or alternatively, 
the UV-induced checkpoint response is merely a secondary observation in a system 
designed to maintain genomic stability during the well regulated replication of a complex 
genome. Although much research is still needed, these observations, along with the data 
presented here question whether inhibition of the intra-S checkpoint alone is a plausible 
mechanism for inducing a mutator phenotype in cancer cells. It has even been suggested 
that the UVA component of UVR might itself inhibit DNA damage responses (Kappes et al., 
2006; Runger and Kappes, 2008), including the intra-S checkpoint (de Laat et al., 1997; 
Runger and Kappes, 2008), potentially contributing to the enhanced mutagenesis that some  
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investigators have reported with longer wavelengths of UVR. Within the limitations of our 
model system, not only did we fail to observe UVA-induced inhibition of the intra-S 
checkpoint or an increased mutation frequency in UVA-irradiated cells, but we also cannot 
conclude that intra-S checkpoint inhibition increases UV-induced mutation frequency.
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